Processing 00000000.tx.1: Analysis of the butyrylcholinesterase gene and nearby chromosome 3 markers in Alzheimer disease N. 

Phrase: "Analysis of the butyrylcholinesterase gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "nearby chromosome 3 markers in Alzheimer disease N."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   767   C0008631:Chromosome Markers [Cell or Molecular Dysfunction]
   767   C1511983:Markers, Disease [Idea or Concept]
   750 E C2919537:Marker chromosome [Disease or Syndrome]
   711   C0005516:Marker [Clinical Attribute]
Processing 00000000.tx.2: Brindle+, Y. 

Phrase: "Brindle+,"

Phrase: "Y."
Processing 00000000.tx.3: Song+, E. 

Phrase: "Song+,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0872005:Song [Intellectual Product]

Phrase: "E."
Processing 00000000.tx.4: Rogaeva+, S. 

Phrase: "Rogaeva+,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.5: Premkumar1, G. 

Phrase: "Premkumar1,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.6: Levesque, G. 

Phrase: "Levesque,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.7: Yu, M. 

Phrase: "Yu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1006780:yu [Plant]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.8: Ikeda, M. 

Phrase: "Ikeda,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3613423:Ikeda [Eukaryote]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.9: Nishimura, A. 

Phrase: "Nishimura,"

Phrase: "A."
Processing 00000000.tx.10: Paterson2, S. 

Phrase: "Paterson2,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.11: Sorbi3, R. 

Phrase: "Sorbi3,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.12: Duara4, L. 

Phrase: "Duara4,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.13: Farrer1, P. 

Phrase: "Farrer1,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.14: St George-Hyslop* Centre for Research in Neurodegenerative Diseases, Department of Medicine (Division of Neurology), University of Toronto, and Department of Medicine (Division of Neurology), The Toronto Hospital, Tanz Neuroscience Building, 6 Queen's Park Crescent, Toronto, Ontario M5S 3H2, Canada, 1Neurogenetics Laboratory, Department of Neurology, Boston University School of Medicine, 80 East Concord Street, Boston, MA 02118, USA, 2Neurogenetics Laboratory, Clarke Institute of Psychiatry, University of Toronto, College Street, Toronto, Ontario, Canada, 3Department of Neurology and Psychiatry, 85 viale Morgagni, 50134 Firenze, Italy and 4Department of Neurology, Wein Center, Mount Sinai Medical Centre, 4300 Alto Road, Miami Beach, FL 33140, USA Received November 28, 1997; 

Phrase: "St George-Hyslop"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1553316:St. George [Population Group]

Phrase: "* Centre for Research"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   858   C0683939:center research [Manufactured Object,Organization]
   790   C0205099:Center [Spatial Concept]

Phrase: "in Neurodegenerative Diseases,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0524851:Neurodegenerative Diseases [Disease or Syndrome]
   861   C0012634:Diseases [Disease or Syndrome]
   789 E C1836721:MALS [Finding]
   789 E C3538764:MALS [Gene or Genome]
   789 E C3540595:MAL [Gene or Genome]

Phrase: "Department of Medicine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1704729:Department [Organization]

Phrase: "(Division of Neurology"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   811   C0228059:division nervous system [Body System]
   790   C1293097:Division [Therapeutic or Preventive Procedure]
   790   C2919030:Division [Organization]
   790   C2919031:Division [Activity]

Phrase: ")"

Phrase: ","

Phrase: "University of Toronto,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "and"

Phrase: "Department of Medicine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1704729:Department [Organization]

Phrase: "(Division of Neurology"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   811   C0228059:division nervous system [Body System]
   790   C1293097:Division [Therapeutic or Preventive Procedure]
   790   C2919030:Division [Organization]
   790   C2919031:Division [Activity]

Phrase: ")"

Phrase: ","

Phrase: "The Toronto Hospital,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0019994:Hospital, NOS [Health Care Related Organization,Manufactured Object]
   861   C1510665:Hospital [Qualitative Concept]
   777 E C1609061:Hospitals [Intellectual Product]

Phrase: "Tanz Neuroscience Building,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1547706:Building [Functional Concept]
   827   C1999269:Building [Manufactured Object]

Phrase: "6 Queen's Park Crescent,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0444628:crescent [Spatial Concept]

Phrase: "Toronto,"

Phrase: "Ontario M5S 3H2,"

Phrase: "Canada,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006823:Canada [Geographic Area]

Phrase: "1Neurogenetics Laboratory,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0022877:Laboratory [Manufactured Object,Organization]
   861   C3244292:laboratory [Functional Concept]

Phrase: "Department of Neurology,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   858   C0587475:Neurology department [Health Care Related Organization]
   790   C1704729:Department [Organization]

Phrase: "Boston University School of Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0036375:School [Manufactured Object,Organization]

Phrase: "80 East Concord Street,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0442658:Street [Manufactured Object]
   812   C1301826:Street [Finding]

Phrase: "Boston,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006037:Boston [Geographic Area]

Phrase: "MA 02118,"

Phrase: "USA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: "2Neurogenetics Laboratory,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0022877:Laboratory [Manufactured Object,Organization]
   861   C3244292:laboratory [Functional Concept]

Phrase: "Clarke Institute of Psychiatry,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0021622:institute [Organization]
   770   C1272753:Institute [Idea or Concept]

Phrase: "University of Toronto,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "College Street,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0442658:Street [Manufactured Object]
   861   C1301826:Street [Finding]

Phrase: "Toronto,"

Phrase: "Ontario,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0029040:Ontario [Geographic Area]

Phrase: "Canada,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006823:Canada [Geographic Area]

Phrase: "3Department of Neurology"

Phrase: "and"

Phrase: "Psychiatry,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0033872:Psychiatry [Professional or Occupational Group]
  1000   C0033873:Psychiatry [Biomedical Occupation or Discipline]
   928 E C0205487:Psychiatric [Functional Concept]

Phrase: "85 viale Morgagni,"

Phrase: "50134 Firenze,"

Phrase: "Italy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022277:Italy [Geographic Area]

Phrase: "and"

Phrase: "4Department of Neurology,"

Phrase: "Wein Center,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205099:Center [Spatial Concept]

Phrase: "Mount Sinai Medical Centre,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0565990:Medical center [Health Care Related Organization,Manufactured Object]
   861   C1552471:Medical Center [Health Care Related Organization,Manufactured Object]
   812   C0205099:Center [Spatial Concept]
   812   C0205476:Medical [Functional Concept]

Phrase: "4300 Alto Road,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0442650:Road [Manufactured Object]

Phrase: "Miami Beach,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0331781:Beach [Geographic Area]

Phrase: "FL 33140,"

Phrase: "USA Received November 28,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0041703:USA [Geographic Area]
   812   C1514756:Received [Qualitative Concept]

Phrase: "1997"

Phrase: ";"
Processing 00000000.tx.15: Revised and Accepted January 30, 1998 The K-variant of butyrylcholinesterase (BCHE-K) recently has been reported to be associated with Alzheimer disease (AD) in carriers of the [epsis]4 allele of the apolipoprotein E (APOE) gene. 

Phrase: "Revised"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1527075:Revised [Therapeutic or Preventive Procedure]
   966 E C3244319:revise [Functional Concept]

Phrase: "and"

Phrase: "Accepted January 30,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1272684:Accepted [Qualitative Concept]
   827   C1548435:Accepted [Idea or Concept]

Phrase: "1998"

Phrase: "The K-variant of butyrylcholinesterase (BCHE-K) recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205419:Variant [Qualitative Concept]

Phrase: "has"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "associated with Alzheimer disease (AD)"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   833   C0002395:Alzheimer's Disease [Disease or Syndrome]
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   833   C1521724:Alzheimer's Disease [Pathologic Function]
   819   C0243083:associated disease [Pathologic Function]
   770   C0012634:Disease [Disease or Syndrome]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: "in carriers"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0007294:carriers [Finding]
   966 E C0560175:Carrier [Finding]
   966 E C1706209:Carrier [Medical Device]
   966 E C3273162:Carrier [Intellectual Product]

Phrase: "of the [epsis"

Phrase: "]4 allele of the apolipoprotein E (APOE) gene."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   835   C3642141:Apolipoprotein E*4 Allele [Gene or Genome]
   748   C0002085:Allele [Gene or Genome]
           allelic gene
Processing 00000000.tx.16: We have re-examined the frequency of the BCHE-K allele in a large data set of both sporadic and familial cases of AD disease, and we have also examined the segregation of three genetic markers on chromosome 3 near BCHE. 

Phrase: "We"

Phrase: "have"

Phrase: "re-examined"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332128:Examined [Finding]
   861   C2986904:RE [Idea or Concept]

Phrase: "the frequency of the BCHE-K allele"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   783   C0017270:Allele Frequency [Quantitative Concept]
   753   C0376249:frequency [Quantitative Concept]
   753   C0439603:Frequency [Temporal Concept]
   753   C0871396:Frequency [Quantitative Concept]
   753   C1561548:Frequency [Qualitative Concept]
   753   C1705502:Frequency [Quantitative Concept]

Phrase: "in a large data set"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C0150098:Data Set [Intellectual Product]
   901   C1706233:Dataset [Intellectual Product]
   827   C0036849:Set [Mental Process]
   827   C1442518:Set [Functional Concept]
   827   C1511726:Data [Idea or Concept]
   827   C1705195:Set [Conceptual Entity]
   827   C3245479:data [Medical Device]

Phrase: "of both sporadic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205422:Sporadic [Temporal Concept]

Phrase: "and"

Phrase: "familial cases of AD disease,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   753   C0868928:Cases [Functional Concept]
   753   C1533148:Cases [Quantitative Concept]
   719 E C1706255:CASE [Medical Device]
   719 E C1706256:Case [Conceptual Entity]

Phrase: "and"

Phrase: "we"

Phrase: "have"

Phrase: "also"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the segregation of three genetic markers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0080141:segregation [Social Behavior]

Phrase: "on chromosome 3 near BCHE."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0728810:Butyrylcholinesterase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C1412756:BUTYRYLCHOLINESTERASE [Gene or Genome]
Processing 00000000.tx.17: Our data neither support an association of BCHE-K with sporadic or familial AD, nor do they suggest the existence of another gene nearby on chromosome 3 as a common cause of familial AD. 

Phrase: "Our data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "neither"

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "an association of BCHE-K"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0004083:Association [Mental Process]
   770   C0439849:Association [Qualitative Concept]
   770   C0596306:Association [Phenomenon or Process]
   770   C0699792:association [Social Behavior]

Phrase: "with sporadic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205422:Sporadic [Temporal Concept]

Phrase: "or"

Phrase: "familial AD,"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   913   C0277558:Familial disease [Disease or Syndrome]
   901   C0002395:Alzheimer's Disease [Disease or Syndrome]
   901   C1521724:Alzheimer's Disease [Pathologic Function]
   877 E C0344339:family disease [Finding]
   827   C0012634:Disease [Disease or Syndrome]
   827   C0015576:familial [Family Group]
   827   C0241888:Familial [Functional Concept]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]
   755 E C1704727:Family [Conceptual Entity]

Phrase: "nor"

Phrase: "do"

Phrase: "they"

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "the existence of another gene"

Phrase: "nearby on chromosome 3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1706276:Nearby [Qualitative Concept]

Phrase: "as a common cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0015127:cause [Functional Concept]
   861   C1524003:Cause [Conceptual Entity]

Phrase: "of familial AD."
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   913   C0277558:Familial disease [Disease or Syndrome]
   901   C0002395:Alzheimer's Disease [Disease or Syndrome]
   901   C1521724:Alzheimer's Disease [Pathologic Function]
   877 E C0344339:family disease [Finding]
   827   C0012634:Disease [Disease or Syndrome]
   827   C0015576:familial [Family Group]
   827   C0241888:Familial [Functional Concept]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]
   755 E C1704727:Family [Conceptual Entity]
Processing 00000000.tx.18: INTRODUCTION The butyrylcholinesterase (BCHE) gene contains two common polymorphic variants. 

Phrase: "INTRODUCTION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1293116:Introduction [Health Care Activity]
  1000   C1875307:INTRODUCTION [Manufactured Object]

Phrase: "The butyrylcholinesterase (BCHE) gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1412756:Butyrylcholinesterase Gene [Gene or Genome]
   861   C0017337:Gene [Gene or Genome]

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "two common polymorphic variants."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0205419:variants [Qualitative Concept]
Processing 00000000.tx.19: One of these polymorphisms, the K-variant (BCHE-K) arises from a G->A substitution at nucleotide 1615 and causes an Ala539Thr missense substitution which reduces the catalytic activity of BCHE enzyme (1). 

Phrase: "One of these polymorphisms,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205447:One [Quantitative Concept]

Phrase: "the K-variant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205419:Variant [Qualitative Concept]

Phrase: "(BCHE-K"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0728810:Butyrylcholinesterase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1412756:BUTYRYLCHOLINESTERASE [Gene or Genome]

Phrase: ")"

Phrase: "arises from a G->A substitution"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0439267:g% [Quantitative Concept]
   753   C1555721:Substitution [Idea or Concept]
   753   C1706204:Substitution [Activity]

Phrase: "at nucleotide 1615"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "an Ala539Thr missense substitution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1555721:Substitution [Idea or Concept]
   827   C1706204:Substitution [Activity]

Phrase: "which"

Phrase: "reduces"

Phrase: "the catalytic activity of BCHE enzyme"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C0243102:catalytic activity [Molecular Function]
           enzyme activity
   790   C1264638:Catalytic activity [Functional Concept]
   790   C1547012:*Catalytic Activity [Quantitative Concept]
   783   C1149831:butyrylcholinesterase activity [Molecular Function]
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1561536:*Activity [Idea or Concept]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.20: Recently, the BCHE-K variant has been reported to show allelic association with Alzheimer disease (AD) in subjects who are also carriers of the [epsis]4 allele of apolipoprotein E (APOE), especially in subjects over the age of 75 years (2). 

Phrase: "Recently,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "the BCHE-K variant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205419:Variant [Qualitative Concept]

Phrase: "has"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "allelic association with Alzheimer disease"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   797   C1511978:Disease Association [Temporal Concept]
   760   C0004083:Association [Mental Process]
   760   C0439849:Association [Qualitative Concept]
   760   C0596306:Association [Phenomenon or Process]
   760   C0699792:association [Social Behavior]

Phrase: "(AD"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: ")"

Phrase: "in subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0681850:Subject [Group]
   966   C1550501:{Subject} [Idea or Concept]
   966   C1706203:Subject [Idea or Concept]
   966   C2349001:Subject [Human]
   966   C2697811:Subject [Functional Concept]

Phrase: "who"

Phrase: "are"

Phrase: "also carriers of the [epsis"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0007294:carriers [Finding]
   726 E C0560175:Carrier [Finding]
   726 E C1706209:Carrier [Medical Device]
   726 E C3273162:Carrier [Intellectual Product]

Phrase: "]4 allele of apolipoprotein E"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   891   C3642141:Apolipoprotein E*4 Allele [Gene or Genome]
   760   C0002085:Allele [Gene or Genome]

Phrase: "(APOE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: ","

Phrase: "especially in subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   756   C0681850:Subject [Group]
   756   C1550501:{Subject} [Idea or Concept]
   756   C1706203:Subject [Idea or Concept]
   756   C2349001:Subject [Human]
   756   C2697811:Subject [Functional Concept]

Phrase: "over the age"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "of 75 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439234:years [Temporal Concept]
   827 E C0439508:/year [Temporal Concept]

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.21: We have re-examined the frequency of BCHE-K in subjects with late onset sporadic AD or with familial AD (FAD). 

Phrase: "We"

Phrase: "have"

Phrase: "re-examined"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332128:Examined [Finding]
   861   C2986904:RE [Idea or Concept]

Phrase: "the frequency of BCHE-K"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0376249:frequency [Quantitative Concept]
   770   C0439603:Frequency [Temporal Concept]
   770   C0871396:Frequency [Quantitative Concept]
   770   C1561548:Frequency [Qualitative Concept]
   770   C1705502:Frequency [Quantitative Concept]

Phrase: "in subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0681850:Subject [Group]
   966   C1550501:{Subject} [Idea or Concept]
   966   C1706203:Subject [Idea or Concept]
   966   C2349001:Subject [Human]
   966   C2697811:Subject [Functional Concept]

Phrase: "with late onset sporadic AD"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   924   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]
   840   C0002395:Alzheimer's Disease [Disease or Syndrome]
   840   C1521724:Alzheimer's Disease [Pathologic Function]
   804   C0012634:Disease [Disease or Syndrome]
   804   C0205422:Sporadic [Temporal Concept]
   748 E C1836721:MALS [Finding]
   748 E C3538764:MALS [Gene or Genome]
   748 E C3540595:MAL [Gene or Genome]

Phrase: "or with familial AD (FAD)."
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   862   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   806   C0002395:Alzheimer's Disease [Disease or Syndrome]
   806   C1521724:Alzheimer's Disease [Pathologic Function]
   797   C0277558:Familial disease [Disease or Syndrome]
   762 E C0344339:disease family [Finding]
   760   C0012634:Disease [Disease or Syndrome]
   760   C0015576:familial [Family Group]
   760   C0241888:Familial [Functional Concept]
   704 E C1836721:MALS [Finding]
   704 E C3538764:MALS [Gene or Genome]
   704 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.22: We have also examined the segregation of two informative polymorphic markers located on chromosome 3 flanking the BCHE locus. 

Phrase: "We"

Phrase: "have"

Phrase: "also"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the segregation of two informative polymorphic markers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0080141:segregation [Social Behavior]

Phrase: "located on chromosome 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0008666:Chromosome 3 [Cell Component]
   770   C0008633:Chromosome [Cell Component]

Phrase: "flanking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0230171:flanking [Body Location or Region]

Phrase: "the BCHE locus."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708726:Locus [Gene or Genome]
Processing 00000000.tx.23: RESULTS The genotype at the BCHE locus was determined using two independent methods. 

Phrase: "RESULTS"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "The genotype at the BCHE locus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0017431:Genotype [Organism Attribute]

Phrase: "was"

Phrase: "determined"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "two independent methods."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0025663:Methods [Intellectual Product]
   827   C0025664:methods [Intellectual Product]
   827   C0449851:Methods [Functional Concept]
   793 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.24: Initially, we screened for the presence of the BCHE-K variant using the previously published PCR-based amplification-created restriction site method (2,3), and a simpler method based upon allele-specific oligonucleotides (ASOs) to detect the wild-type and BCHE-K alleles. 

Phrase: "Initially,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205265:Initially [Temporal Concept]

Phrase: "we"

Phrase: "screened for the presence of the BCHE-K variant"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   744   C0205419:Variant [Qualitative Concept]
   744   C0392148:Presence [Therapeutic or Preventive Procedure]
   744   C0728810:Butyrylcholinesterase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C1412756:BUTYRYLCHOLINESTERASE [Gene or Genome]
   711   C0220908:screen [Health Care Activity]
   711   C1305399:screen [Functional Concept]
   711   C1705053:Screen [Medical Device]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the previously published PCR-based amplification-created restriction site method"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   791   C0025663:Method [Intellectual Product]
   791   C0449851:Method [Functional Concept]
   791   C0871511:METHOD [Intellectual Product]

Phrase: "(2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "a simpler method"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025663:Method [Intellectual Product]
   861   C0449851:Method [Functional Concept]
   861   C0871511:METHOD [Intellectual Product]

Phrase: "based upon allele-specific oligonucleotides (ASOs) to"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   753   C0002085:Allele [Gene or Genome]
   753   C0028953:Oligonucleotides [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0205369:Specific [Qualitative Concept]
   753   C1527178:Based [Functional Concept]
   753   C1552740:specific [Intellectual Product]
   753   C1705938:Based [Idea or Concept]
   719 E C0002055:base [Inorganic Chemical]
   719 E C0178499:Base [Chemical Viewed Functionally]
   719 E C1880279:Base [Biomedical or Dental Material]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "the wild-type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "BCHE-K alleles."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Alleles [Gene or Genome]
Processing 00000000.tx.25: A total of 353 Caucasian subjects were genotyped for both BCHE and for APOE. 

Phrase: "A total of 353 Caucasian subjects"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0439175:% total [Quantitative Concept]
   753   C0439810:Total [Qualitative Concept]

Phrase: "were"

Phrase: "genotyped for both BCHE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0728810:Butyrylcholinesterase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C1412756:BUTYRYLCHOLINESTERASE [Gene or Genome]
   737   C0017431:Genotype [Organism Attribute]

Phrase: "and for APOE."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1515981:And [Idea or Concept]
Processing 00000000.tx.26: While the APOE [epsis]4 allele frequency in subjects with AD showed the expected increase in the [epsis]4 allele frequency relative to control subjects (Table 1), there was no difference in the BCHE-K allele frequency between control subjects (n = 165) and subjects with either sporadic AD (n = 138) or unrelated subjects with FAD (n = 50) (Table 1). 

Phrase: "While"

Phrase: "the APOE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "[epsis"

Phrase: "]4 allele frequency in subjects"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0017270:Allele Frequency [Quantitative Concept]
   760   C0376249:frequency [Quantitative Concept]
   760   C0439603:Frequency [Temporal Concept]
   760   C0871396:Frequency [Quantitative Concept]
   760   C1561548:Frequency [Qualitative Concept]
   760   C1705502:Frequency [Quantitative Concept]

Phrase: "with AD"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "the expected increase in the [epsis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0442805:Increase [Functional Concept]

Phrase: "]4 allele frequency relative to control subjects"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   795   C0243148:control [Qualitative Concept]
   795   C1550141:Control [Substance]
   795   C1882979:Control [Conceptual Entity]
   795   C2587213:Control [Functional Concept]
   795   C3274648:Control [Qualitative Concept]
   762   C0681850:Subject [Group]
   762   C1550501:{Subject} [Idea or Concept]
   762   C1706203:Subject [Idea or Concept]
   762   C2349001:Subject [Human]
   762   C2697811:Subject [Functional Concept]

Phrase: "(Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "there"

Phrase: "was"

Phrase: "no difference in the BCHE-K allele frequency"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1705241:*Difference [Quantitative Concept]
   748   C1705242:Difference [Qualitative Concept]

Phrase: "between control subjects"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
   827   C0681850:Subject [Group]
   827   C1550501:{Subject} [Idea or Concept]
   827   C1706203:Subject [Idea or Concept]
   827   C2349001:Subject [Human]
   827   C2697811:Subject [Functional Concept]

Phrase: "(n = 165"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "subjects with either sporadic AD"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C0002395:Alzheimer's Disease [Disease or Syndrome]
   790   C1521724:Alzheimer's Disease [Pathologic Function]
   753   C0012634:Disease [Disease or Syndrome]
   753   C0205422:Sporadic [Temporal Concept]
   753   C0681850:Subject [Group]
   753   C1550501:{Subject} [Idea or Concept]
   753   C1706203:Subject [Idea or Concept]
   753   C2349001:Subject [Human]
   753   C2697811:Subject [Functional Concept]

Phrase: "(n = 138"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "or"

Phrase: "unrelated subjects with FAD (n = 50"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   714   C0681850:Subject [Group]
   714   C1550501:{Subject} [Idea or Concept]
   714   C1706203:Subject [Idea or Concept]
   714   C2349001:Subject [Human]
   714   C2697811:Subject [Functional Concept]

Phrase: ")"

Phrase: "(Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.27: There was also no significant difference in BCHE-K allele frequency between cases and controls even when each subgroup was stratified either by age (using the mean censoring age of 70 years as the cut-off) or by APOE genotype (Table 2). 

Phrase: "There"

Phrase: "was"

Phrase: "also"

Phrase: "no significant difference in BCHE-K allele frequency"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1705241:*Difference [Quantitative Concept]
   748   C1705242:Difference [Qualitative Concept]

Phrase: "between cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0868928:Cases [Functional Concept]
  1000   C1533148:Cases [Quantitative Concept]
   966 E C1706255:CASE [Medical Device]
   966 E C1706256:Case [Conceptual Entity]

Phrase: "and"

Phrase: "controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "even"

Phrase: "when"

Phrase: "each subgroup"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1079230:subgroup [Virus]
  1000   C1515021:Subgroup [Classification]

Phrase: "was"

Phrase: "stratified"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205363:Stratified [Qualitative Concept]

Phrase: "either by age ("
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0001779:Age [Organism Attribute]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the mean censoring age of 70 years"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C1510829:Age-Years [Temporal Concept]
   748   C0001779:Age [Organism Attribute]

Phrase: "as the cut-off"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1442160:Cutoff [Functional Concept]
   861   C0000925:Cut [Injury or Poisoning]
   861   C1883724:CUT [Phenomenon or Process]

Phrase: ")"

Phrase: "or by APOE genotype"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0017431:Genotype [Organism Attribute]

Phrase: "(Table 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.28: Power calculations, however, indicate that using the sample sizes in Table 1, we would have at least an 80% power to detect a difference of 7-17% in BCHE-K allele frequency (depending on the actual population frequency) at the 5% significance level. 

Phrase: "Power calculations,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1441506:Calculation [Activity]

Phrase: "however,"

Phrase: "indicate"

Phrase: "that"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the sample"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0370003:Sample [Substance]
  1000   C2347026:Sample [Conceptual Entity]

Phrase: "sizes in Table 1,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0039224:Table [Manufactured Object]
   770   C0456389:SIZES [Spatial Concept]
   770   C1706073:Table [Medical Device]
   770   C1706074:Table [Intellectual Product]

Phrase: "we"

Phrase: "would"

Phrase: "have at least"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C3154893:Have [Idea or Concept]
   790   C3539897:Have [Qualitative Concept]

Phrase: "an 80% power to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0032863:Power [Human-caused Phenomenon or Process]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "a difference of 7-17%"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1705241:*Difference [Quantitative Concept]
   760   C1705242:Difference [Qualitative Concept]

Phrase: "in BCHE-K allele frequency"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   901   C0017270:Allele Frequency [Quantitative Concept]
   827   C0376249:frequency [Quantitative Concept]
   827   C0439603:Frequency [Temporal Concept]
   827   C0871396:Frequency [Quantitative Concept]
   827   C1561548:Frequency [Qualitative Concept]
   827   C1705502:Frequency [Quantitative Concept]
   755 E C0332183:Frequent [Temporal Concept]

Phrase: "("

Phrase: "depending on the actual population frequency"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   790   C0017270:Population Frequency [Quantitative Concept]
   753   C0032659:Population [Quantitative Concept]
   753   C0237400:Actual [Qualitative Concept]
   753   C0376249:frequency [Quantitative Concept]
   753   C0439603:Frequency [Temporal Concept]
   753   C0871396:Frequency [Quantitative Concept]
   753   C1257890:Population [Population Group]
   753   C1561548:Frequency [Qualitative Concept]
   753   C1705502:Frequency [Quantitative Concept]
   719   C0725813:depend [Medical Device]

Phrase: ")"

Phrase: "at the 5% significance level."
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   913   C0456951:5 level [Qualitative Concept]
   901   C0814896:Significance Level [Research Activity]
   827   C0237881:Significance [Quantitative Concept]
   827   C0441889:Level [Qualitative Concept]
   827   C0456079:Level [Classification]
   827   C0750502:Significance [Idea or Concept]
   827   C1547707:Level [Geographic Area]
   827   C2946261:Level [Pharmacologic Substance]
   755 E C1546944:Significant [Qualitative Concept]
Processing 00000000.tx.29: To test for the possibility that an effect of BCHE-K is masked or confounded with APOE genotype, we performed multiple logistic regression analysis including BCHE and APOE genotypes as predictors of disease outcome, adjusting for age and sex (4). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "test for the possibility"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0022885:Test [Laboratory Procedure]
   770   C0039593:Test [Functional Concept]
   770   C0392366:test [Intellectual Product]

Phrase: "that"

Phrase: "an effect of BCHE-K"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "is"

Phrase: "masked"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0150108:masked [Research Activity]
  1000   C0150112:MASKED [Functional Concept]
  1000   C1555580:masked [Idea or Concept]
   966 E C0024861:Mask [Medical Device]
   966 E C1538279:MASK [Gene or Genome]
   966 E C1845191:MASK [Gene or Genome]

Phrase: "or"

Phrase: "confounded with APOE genotype,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0017431:Genotype [Organism Attribute]

Phrase: "we"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "multiple logistic regression analysis"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   923   C0681925:logistic regression analysis [Research Activity]
   861   C0034980:Regression Analysis [Intellectual Product]
   812   C0002778:Analysis [Laboratory Procedure]
   812   C0936012:Analysis [Research Activity]
   812   C1524024:analysis [Functional Concept]
   708   C0681923:multiple regression [Qualitative Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "BCHE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0728810:Butyrylcholinesterase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1412756:BUTYRYLCHOLINESTERASE [Gene or Genome]

Phrase: "and"

Phrase: "APOE genotypes as predictors of disease outcome,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0017431:Genotypes [Organism Attribute]

Phrase: "adjusting for age"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0001779:Age [Organism Attribute]

Phrase: "and"

Phrase: "sex"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0009253:Sex [Organism Function]
  1000   C0036864:Sex [Behavior]
  1000   C0079399:sex [Organism Attribute]
  1000   C1314687:Sex [Finding]
  1000   C1522384:sex [Organism Attribute]

Phrase: "(4"

Phrase: ")."
Processing 00000000.tx.30: While APOE [epsis]4 was found to confer a significant 4.6-fold increase in risk for AD [95% confidence interval (CI) 2.4-8.6], the odds ratio of 1.6 obtained for BCHE-K was not significantly different from one (95% CI: 0.86-3.0). 

Phrase: "While"

Phrase: "APOE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "[epsis"

Phrase: "]4"

Phrase: "was"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "confer"

Phrase: "a significant 4.6-fold increase in risk"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0442805:Increase [Functional Concept]

Phrase: "for AD"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "[95% confidence interval (CI) 2.4-8.6"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   818   C0009667:Confidence Interval [Quantitative Concept]
   795   C0237529:Confidence [Mental Process]
   795   C1272706:Interval [Temporal Concept]
   795   C1552654:Interval [Idea or Concept]
   795   C1552713:Interval [Intellectual Product]
   795   C1704725:Confidence [Qualitative Concept]
   795   C1704726:Confidence [Mental Process]
   724 E C0558095:Confident [Individual Behavior]

Phrase: "],"

Phrase: "the odds ratio of 1.6"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0028873:Odds Ratio [Quantitative Concept]
   753   C0456603:Ratio [Quantitative Concept]
   753   C1547037:Ratio [Intellectual Product]

Phrase: "obtained for BCHE-K"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0728810:Butyrylcholinesterase [Amino Acid, Peptide, or Protein,Enzyme]
   790   C1301820:Obtained [Functional Concept]
   790   C1412756:BUTYRYLCHOLINESTERASE [Gene or Genome]
   756 E C1706701:Obtain [Activity]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "was"

Phrase: "not significantly different from one (95% CI"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1705242:Different [Qualitative Concept]

Phrase: ":"

Phrase: "0.86-3.0"

Phrase: ")."
Processing 00000000.tx.31: Our data therefore do not confirm an association between BCHE-K and AD, nor do they suggest a synergistic interaction between BCHE-K and the [epsis]4 allele of APOE. 

Phrase: "Our data therefore"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "an association between BCHE-K"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0004083:Association [Mental Process]
   770   C0439849:Association [Qualitative Concept]
   770   C0596306:Association [Phenomenon or Process]
   770   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "AD,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "nor"

Phrase: "do"

Phrase: "they"

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "a synergistic interaction between BCHE-K"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "the [epsis"

Phrase: "]4 allele of APOE."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   891   C3642141:Apolipoprotein E*4 Allele [Gene or Genome]
   760   C0002085:Allele [Gene or Genome]
Processing 00000000.tx.32: Table 1. 

Phrase: "Table 1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.33: Age, sex, APOE and BCHE allele frequencies in AD, FAD and control subjects Group No. 

Phrase: "Age,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "sex,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0009253:Sex [Organism Function]
  1000   C0036864:Sex [Behavior]
  1000   C0079399:sex [Organism Attribute]
  1000   C1314687:Sex [Finding]
  1000   C1522384:sex [Organism Attribute]

Phrase: "APOE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "BCHE allele frequencies in AD,"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   790   C0017270:Frequencies, Allele [Quantitative Concept]
   753   C0439603:Frequencies [Temporal Concept]
   719 E C0376249:frequency [Quantitative Concept]
   719 E C0871396:Frequency [Quantitative Concept]
   719 E C1561548:Frequency [Qualitative Concept]
   719 E C1705502:Frequency [Quantitative Concept]

Phrase: "FAD"

Phrase: "and"

Phrase: "control subjects Group"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   913   C0009932:Control Group [Group]
   827   C0441833:Group [Idea or Concept]
   827   C0687744:group [Population Group]
   827   C1257890:Group [Population Group]
   827   C1552516:Group [Health Care Related Organization]
   827   C1705428:Group [Conceptual Entity]
   827   C1705429:Group [Population Group]

Phrase: "No."
Processing 00000000.tx.34: Mean F:M APOE allele frequency (%) BCHE allele frequency (%)   age ratio [epsis]2 [epsis]3 [epsis]4 W K Alzheimer 138 75.4 1:8 2.3 66.3 31.4 79.7 20.3 FAD 50 67.2 2.2 2.1 48.9 49.0 76.0 18.8 Control 165 63.4 0.8 7.5 78.5 14.0 81.2 18.8 Table 2. 

Phrase: "Mean F:M APOE allele frequency"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   818   C0017270:Allele Frequency [Quantitative Concept]
   795   C0376249:frequency [Quantitative Concept]
   795   C0439603:Frequency [Temporal Concept]
   795   C0871396:Frequency [Quantitative Concept]
   795   C1561548:Frequency [Qualitative Concept]
   795   C1705502:Frequency [Quantitative Concept]
   724 E C0332183:Frequent [Temporal Concept]

Phrase: "(%"

Phrase: ")"

Phrase: "BCHE allele frequency"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   901   C0017270:Allele Frequency [Quantitative Concept]
   827   C0376249:frequency [Quantitative Concept]
   827   C0439603:Frequency [Temporal Concept]
   827   C0871396:Frequency [Quantitative Concept]
   827   C1561548:Frequency [Qualitative Concept]
   827   C1705502:Frequency [Quantitative Concept]
   755 E C0332183:Frequent [Temporal Concept]

Phrase: "(%"

Phrase: ")"

Phrase: "age ratio"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0456603:Ratio [Quantitative Concept]
   861   C1547037:Ratio [Intellectual Product]

Phrase: "[epsis"

Phrase: "]2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "[epsis"

Phrase: "]3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "[epsis"

Phrase: "]4 W K Alzheimer 138 75.4 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   793   C1708601:K' [Quantitative Concept]

Phrase: ":"

Phrase: "8 2.3 66.3 31.4 79.7 20.3 FAD 50 67.2 2.2 2.1 48.9 49.0 76.0 18.8 Control 165 63.4 0.8 7.5 78.5 14.0 81.2 18.8 Table 2."
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
   835   C0050718:AD 5 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   809   C0444499:0/5 [Quantitative Concept]
   799   C0295428:AD 48 [Organic Chemical,Pharmacologic Substance]
   780   C0015576:familial [Family Group]
   780   C0039224:Table [Manufactured Object]
   780   C0241888:Familial [Functional Concept]
   780   C0243148:control [Qualitative Concept]
   780   C0450355:31 [Intellectual Product]
   780   C1550141:Control [Substance]
   780   C1706073:Table [Medical Device]
   780   C1706074:Table [Intellectual Product]
   780   C1882979:Control [Conceptual Entity]
   780   C2587213:Control [Functional Concept]
   780   C3274648:Control [Qualitative Concept]
   708 E C1704727:Family [Conceptual Entity]
Processing 00000000.tx.35: BCHE-K allele frequencies in AD and control subjects Group [le]70 years >70 years APOE [epsis]4+ APOE [epsis]4-  No. 

Phrase: "BCHE-K allele frequencies in AD"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   790   C0017270:Frequencies, Allele [Quantitative Concept]
   753   C0439603:Frequencies [Temporal Concept]
   719 E C0376249:frequency [Quantitative Concept]
   719 E C0871396:Frequency [Quantitative Concept]
   719 E C1561548:Frequency [Qualitative Concept]
   719 E C1705502:Frequency [Quantitative Concept]

Phrase: "and"

Phrase: "control subjects Group"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   913   C0009932:Control Group [Group]
   827   C0441833:Group [Idea or Concept]
   827   C0687744:group [Population Group]
   827   C1257890:Group [Population Group]
   827   C1552516:Group [Health Care Related Organization]
   827   C1705428:Group [Conceptual Entity]
   827   C1705429:Group [Population Group]

Phrase: "[le]70 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0439234:years [Temporal Concept]
   793 E C0439508:/year [Temporal Concept]

Phrase: ">70 years APOE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "[epsis"

Phrase: "]4+ APOE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "[epsis"

Phrase: "]4-"

Phrase: "No."
Processing 00000000.tx.36: f(K) No. 

Phrase: "f("
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "K)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "No."
Processing 00000000.tx.37: f(K) No. 

Phrase: "f("
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "K)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "No."
Processing 00000000.tx.38: f(K) No. 

Phrase: "f("
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "K)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "No."
Processing 00000000.tx.39: f(K) AD 32 28.1 104 18.3 76 19.1 56 30.4 Controls 95 22.1 55 13.6 41 17.1 113 19.9 To examine the possibility that another nearby gene on chromosome 3 might be associated with increased risk for FAD, we examined the segregation of two informative microsatellite markers (D3S1744 and D3S1763) in 56 FAD pedigrees. 

Phrase: "f(K) AD 32 28.1 104 18.3 76 19.1 56 30.4 Controls 95 22.1 55 13.6 41 17.1 113 19.9 To"
Meta Candidates (Total=36; Excluded=3; Pruned=0; Remaining=33)
   878   C1837149:Alzheimer Disease 9 [Disease or Syndrome]
   863   C0243390:K 41 [Organic Chemical,Pharmacologic Substance]
   863   C3554452:ALZHEIMER DISEASE 17 [Disease or Syndrome]
   856   C1854187:Alzheimer Disease 6 [Disease or Syndrome]
   852   C1970147:Alzheimer Disease 13 [Disease or Syndrome]
   837   C0602385:F 4 [Organic Chemical,Pharmacologic Substance]
   833   C0052012:K-4 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   830   C1847200:ALZHEIMER DISEASE 4 [Disease or Syndrome]
   824   C0048433:MAL-6 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   818   C0450334:18/22 [Quantitative Concept]
   815   C0206805:K 76 [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   813   C0920467:disease control [Therapeutic or Preventive Procedure]
   808   C1843013:Alzheimer disease 3 [Disease or Syndrome]
   807   C0064197:K-18 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   798   C0622037:Mal.4 [Organic Chemical,Pharmacologic Substance]
   796   C2931257:Alzheimer disease 1 [Disease or Syndrome]
   785   C0002395:Alzheimer's Disease [Disease or Syndrome]
   785   C1521724:Alzheimer's Disease [Pathologic Function]
   781   C0012634:Disease [Disease or Syndrome]
   781   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   781   C0439133:(f) [Intellectual Product]
   781   C0450382:55 [Intellectual Product]
   781   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   781   C1553038:[f] [Quantitative Concept]
   781   C1708601:K' [Quantitative Concept]
   776   C0067430:MAL-3 [Organic Chemical]
   776   C1425077:MALS-3 [Gene or Genome]
   765   C1425075:MALS-1 [Gene or Genome]
   748   C0243148:control [Qualitative Concept]
   748   C1550141:Control [Substance]
   748   C1882979:Control [Conceptual Entity]
   748   C2587213:Control [Functional Concept]
   748   C3274648:Control [Qualitative Concept]
   726 E C1836721:MALS [Finding]
   726 E C3538764:MALS [Gene or Genome]
   726 E C3540595:MAL [Gene or Genome]

Phrase: "examine"

Phrase: "the possibility"

Phrase: "that"

Phrase: "another nearby gene on chromosome 3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0017337:Gene [Gene or Genome]

Phrase: "might"

Phrase: "be"

Phrase: "associated with increased risk"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0035647:Risk [Qualitative Concept]
   770   C0205217:Increased [Quantitative Concept]
   770   C0442805:Increased [Functional Concept]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "for FAD,"

Phrase: "we"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the segregation of two informative microsatellite markers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0080141:segregation [Social Behavior]

Phrase: "(D3S1744"

Phrase: "and"

Phrase: "D3S1763"

Phrase: ")"

Phrase: "in 56 FAD pedigrees."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0030761:pedigrees [Intellectual Product]
Processing 00000000.tx.40: These markers have been genetically mapped in the order D3S1744-17.7cM-D3S1763 (data obtained from the Genome Database). 

Phrase: "These markers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0005516:Marker [Clinical Attribute]

Phrase: "have"

Phrase: "been"

Phrase: "genetically"

Phrase: "mapped in the order D3S1744-17.7cM-D3S1763"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   744   C1705175:Order [Intellectual Product]
   744   C1705176:Order [Qualitative Concept]
   744   C1705177:Order [Classification]
   744   C1705178:Order [Activity]
   744   C1882348:Order [Qualitative Concept]
   711   C0024779:Map [Manufactured Object]
   711   C1706473:Map [Conceptual Entity]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "obtained from the Genome Database"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   806   C0872346:genome database [Intellectual Product]
   760   C0017428:Genome [Gene or Genome]
   760   C0242356:Database [Intellectual Product]
   760   C0993637:Data Base [Intellectual Product]
   760   C1301820:Obtained [Functional Concept]
   760   C2338314:Genome [Conceptual Entity]
   726 E C1706701:Obtain [Activity]

Phrase: ")."
Processing 00000000.tx.41: The BCHE gene has been physically mapped to a radiation hybrid and yeast contig (WC3.20) as D3S3668, which places BCHE at least 1 cM centromeric of D3S1763. 

Phrase: "The BCHE gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1412756:Butyrylcholinesterase Gene [Gene or Genome]
   861   C0017337:Gene [Gene or Genome]

Phrase: "has"

Phrase: "been"

Phrase: "physically"

Phrase: "mapped to a radiation hybrid"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   827   C1253949:Radiation Hybrid Map [Intellectual Product]
   806   C0887811:Radiation Hybrid [Cell]
   760   C0020205:Hybrid [Organism]
   760   C0034519:Radiation [Natural Phenomenon or Process]
   760   C0560559:Radiation [Quantitative Concept]
   760   C0851346:Radiation [Natural Phenomenon or Process]
   760   C1522449:Radiation [Therapeutic or Preventive Procedure]
   760   C1524020:Radiation [Therapeutic or Preventive Procedure]
   760   C1524021:Radiation [Research Activity]
   726   C0024779:Map [Manufactured Object]
   726   C1706473:Map [Conceptual Entity]

Phrase: "and"

Phrase: "yeast contig"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1511491:Contig [Spatial Concept]

Phrase: "(WC3.20"

Phrase: ")"

Phrase: "as"

Phrase: "D3S3668,"

Phrase: "which"

Phrase: "places"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0442504:Place [Spatial Concept]
  1000   C1704765:Place [Functional Concept]
  1000   C1882509:Place [Activity]
  1000   C3496241:place [Disease or Syndrome]

Phrase: "BCHE at least 1 cM"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0728810:Butyrylcholinesterase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C1412756:BUTYRYLCHOLINESTERASE [Gene or Genome]

Phrase: "centromeric of D3S1763."
Processing 00000000.tx.42: Maximum likelihood calculations excluded linkage in our FAD pedigrees to the entire interval between D3S1744 and D3S1763 regardless of whether an affecteds-only model or age- and sex-dependent penetrance model was used to handle disease status information in asymptomatic relatives. 

Phrase: "Maximum likelihood calculations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1441506:Calculation [Activity]

Phrase: "excluded"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1554077:Excluded [Idea or Concept]
  1000   C2828389:Excluded [Activity]
   966 E C0332196:Exclude [Functional Concept]

Phrase: "linkage in our FAD pedigrees"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0023745:linkage [Molecular Function]

Phrase: "to the entire interval"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1272706:Interval [Temporal Concept]
   861   C1552654:Interval [Idea or Concept]
   861   C1552713:Interval [Intellectual Product]

Phrase: "between D3S1744"

Phrase: "and"

Phrase: "D3S1763 regardless of"

Phrase: "whether"

Phrase: "an affecteds-only model"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C3161035:Model [Intellectual Product]

Phrase: "or"

Phrase: "age-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "and"

Phrase: "sex-dependent penetrance model"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C3161035:Model [Intellectual Product]

Phrase: "was"

Phrase: "used to handle disease status information"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   783   C0587902:Information status [Finding]
   753   C0012634:Disease [Disease or Syndrome]
   753   C0449438:Status [Qualitative Concept]
   753   C1273517:used [Finding]
   753   C1533716:Information [Idea or Concept]
   753   C1708320:Handle [Conceptual Entity]
   719 E C0042153:use [Functional Concept]
   719 E C0457083:Use [Functional Concept]
   719 E C1947944:Use [Intellectual Product]

Phrase: "in asymptomatic relatives."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0080103:Relatives [Family Group]
   827 E C0205345:Relative [Qualitative Concept]
   827 E C1547039:*Relative [Quantitative Concept]
Processing 00000000.tx.43: No evidence was found for linkage in the presence of heterogeneity (P > 0.5), a result which is consistent with the observation that most of the individual family scores were negative, and none exceeded z = +0.5. 

Phrase: "No evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "was"

Phrase: "found for linkage"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0023745:linkage [Molecular Function]
   790   C0150312:Found [Quantitative Concept]
   756 E C0243095:Find [Finding]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of heterogeneity"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0019409:Heterogeneity [Qualitative Concept]
   916 E C1512426:Heterogenous [Idea or Concept]

Phrase: "(P > 0.5"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0444499:0/5 [Quantitative Concept]
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: ","

Phrase: "a result"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "which"

Phrase: "is"

Phrase: "consistent with the observation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "that most of the individual family scores"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0015576:Family [Family Group]
   748   C0027361:Individual [Population Group]
   748   C0237401:Individual [Human]
   748   C0449820:Scores [Quantitative Concept]
   748   C1704727:Family [Conceptual Entity]

Phrase: "were"

Phrase: "negative,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205160:Negative [Qualitative Concept]
  1000   C1513916:Negative [Finding]
  1000   C2825415:Negative [Conceptual Entity]
  1000   C2825491:Negative [Qualitative Concept]

Phrase: "and"

Phrase: "none exceeded z = +0.5."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0444499:0/5 [Quantitative Concept]
Processing 00000000.tx.44: Stratification of the data set into groups of families positive or negative for APOE [epsis]4 and into `age of onset' groups did not suggest the possibility of linkage in any subset even after allowing for linkage heterogeneity within these groups. 

Phrase: "Stratification of the data set"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1514983:Stratification [Research Activity]

Phrase: "into groups"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1552839:groups [Idea or Concept]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]

Phrase: "of families"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015576:Families [Family Group]
  1000   C1704727:Family [Conceptual Entity]
   916 E C0241888:Familial [Functional Concept]

Phrase: "positive"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0439178:% Positive [Quantitative Concept]
  1000   C1446409:Positive [Qualitative Concept]
  1000   C1514241:Positive [Finding]
  1000   C2825490:Positive [Qualitative Concept]

Phrase: "or"

Phrase: "negative for APOE"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0205160:Negative [Qualitative Concept]
   770   C1513916:Negative [Finding]
   770   C2825415:Negative [Conceptual Entity]
   770   C2825491:Negative [Qualitative Concept]

Phrase: "[epsis"

Phrase: "]4"

Phrase: "and into `age of onset' groups"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   833   C0206132:Age of Onset [Quantitative Concept]
           Onset Age
   783   C0027362:Age Group [Age Group]
   783   C2348001:Age Group [Population Group]
   753   C0001779:Age [Organism Attribute]
   753   C0332162:Onset [Qualitative Concept]
   753   C0441833:Group [Idea or Concept]
   753   C0687744:group [Population Group]
   753   C1257890:Group [Population Group]
   753   C1515981:And [Idea or Concept]
   753   C1552516:Group [Health Care Related Organization]
   753   C1552839:groups [Idea or Concept]
   753   C1705428:Group [Conceptual Entity]
   753   C1705429:Group [Population Group]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "the possibility of linkage"

Phrase: "in any subset even"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1515021:Subset [Classification]

Phrase: "after allowing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allowing [Social Behavior]

Phrase: "for linkage heterogeneity"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0019409:Heterogeneity [Qualitative Concept]
   777 E C1512426:Heterogenous [Idea or Concept]

Phrase: "within these groups."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1552839:groups [Idea or Concept]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]
Processing 00000000.tx.45: Repetition of these analyses using non-parametric methods also failed to detect significant evidence for allele sharing in affected relatives (maximum NPL statistic = 1.25, P = 0.25). 

Phrase: "Repetition of these analyses"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205341:repetition [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "non-parametric methods also"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   812   C0025663:Methods [Intellectual Product]
   812   C0025664:methods [Intellectual Product]
   812   C0449851:Methods [Functional Concept]
   779 E C0871511:METHOD [Intellectual Product]

Phrase: "failed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:Failed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "significant evidence for allele sharing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0332120:Evidence [Functional Concept]

Phrase: "in affected relatives"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0080103:Relatives [Family Group]
   827 E C0205345:Relative [Qualitative Concept]
   827 E C1547039:*Relative [Quantitative Concept]

Phrase: "(maximum NPL statistic"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C2348149:Statistic [Quantitative Concept]
   827   C2828391:Statistic [Quantitative Concept]
   755 E C0038215:Statistical [Occupation or Discipline]

Phrase: "= 1.25,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "P = 0.25"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.46: DISCUSSION While our data confirm the well-established association between APOE [epsis]4 and AD (5), our results do not support the notion that the K-variant of BCHE is a risk factor for AD either independently or in association with APOE [epsis]4. 

Phrase: "DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557061:Discussion [Therapeutic or Preventive Procedure]
  1000   C2584313:Discussion [Social Behavior]

Phrase: "While"

Phrase: "our data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "the well-established association between APOE"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0004083:Association [Mental Process]
   748   C0439849:Association [Qualitative Concept]
   748   C0596306:Association [Phenomenon or Process]
   748   C0699792:association [Social Behavior]

Phrase: "[epsis"

Phrase: "]4"

Phrase: "and"

Phrase: "AD"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "our results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "the notion"

Phrase: "that"

Phrase: "the K-variant of BCHE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205419:Variant [Qualitative Concept]

Phrase: "is"

Phrase: "a risk factor for AD either independently"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   793   C0850664:disease risk factor [Finding]
   770   C0035648:Risk factor [Quantitative Concept]
   767   C0050325:A-factor [Biologically Active Substance,Organic Chemical]
   767   C0679238:disease factor [Functional Concept]
   767   C0960756:factor A [Organic Chemical]
   767   C1281905:disease risk [Finding]
   744   C0035647:Risk [Qualitative Concept]
   744   C1521761:Factor [Functional Concept]
   744   C2827422:Factor [Conceptual Entity]

Phrase: "or in association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0004083:Association [Mental Process]
   790   C0439849:Association [Qualitative Concept]
   790   C0596306:Association [Phenomenon or Process]
   790   C0699792:association [Social Behavior]

Phrase: "with APOE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "[epsis"

Phrase: "]4."
Processing 00000000.tx.47: The explanation for the disparity between our data and the previous report is not entirely clear. 

Phrase: "The explanation for the disparity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0681841:Explanation [Intellectual Product]

Phrase: "between our data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "and"

Phrase: "the previous report"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0684224:Report [Intellectual Product]
   861   C0700287:Report [Health Care Activity]
   861   C3273238:Report [Intellectual Product]

Phrase: "is"

Phrase: "not entirely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "clear."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2963144:Clear [Qualitative Concept]
Processing 00000000.tx.48: It is of note, however, that the BCHE-K allele frequency observed in our sporadic AD cases (0.20) and our unrelated FAD cases (0.19) is very similar to that observed in AD cases in the previous report (0.17) (2). 

Phrase: "It"

Phrase: "is of note,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1316572:Note [Clinical Attribute]
   790   C1317574:Note [Intellectual Product]
   790   C1369612:Note [Clinical Attribute]

Phrase: "however,"

Phrase: "that"

Phrase: "the BCHE-K allele frequency"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   901   C0017270:Allele Frequency [Quantitative Concept]
   827   C0376249:frequency [Quantitative Concept]
   827   C0439603:Frequency [Temporal Concept]
   827   C0871396:Frequency [Quantitative Concept]
   827   C1561548:Frequency [Qualitative Concept]
   827   C1705502:Frequency [Quantitative Concept]
   755 E C0332183:Frequent [Temporal Concept]

Phrase: "observed in our sporadic AD cases"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   778   C0002395:Alzheimer's Disease [Disease or Syndrome]
   778   C1521724:Alzheimer's Disease [Pathologic Function]
   748   C0012634:Disease [Disease or Syndrome]
   748   C0205422:Sporadic [Temporal Concept]
   748   C0868928:Cases [Functional Concept]
   748   C1441672:Observed [Functional Concept]
   748   C1533148:Cases [Quantitative Concept]
   714 E C1706255:CASE [Medical Device]
   714 E C1706256:Case [Conceptual Entity]

Phrase: "(0.20"

Phrase: ")"

Phrase: "and"

Phrase: "our unrelated FAD cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   812   C0868928:Cases [Functional Concept]
   812   C1533148:Cases [Quantitative Concept]
   779 E C1706255:CASE [Medical Device]
   779 E C1706256:Case [Conceptual Entity]

Phrase: "(0.19"

Phrase: ")"

Phrase: "is"

Phrase: "very similar to that"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2348205:Similar [Qualitative Concept]

Phrase: "observed in AD cases"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   806   C0002395:Alzheimer's Disease [Disease or Syndrome]
   806   C1521724:Alzheimer's Disease [Pathologic Function]
   760   C0012634:Disease [Disease or Syndrome]
   760   C0868928:Cases [Functional Concept]
   760   C1441672:Observed [Functional Concept]
   760   C1533148:Cases [Quantitative Concept]
   726 E C1706255:CASE [Medical Device]
   726 E C1706256:Case [Conceptual Entity]
   704 E C1836721:MALS [Finding]
   704 E C3538764:MALS [Gene or Genome]
   704 E C3540595:MAL [Gene or Genome]

Phrase: "in the previous report"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0684224:Report [Intellectual Product]
   861   C0700287:Report [Health Care Activity]
   861   C3273238:Report [Intellectual Product]

Phrase: "(0.17"

Phrase: ")"

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.49: In contrast, the BCHE-K frequency in control subjects in our study (0.19) was considerably higher than that in the control group of the previous report (0.09) (2). 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "the BCHE-K frequency in control subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0376249:frequency [Quantitative Concept]
   753   C0439603:Frequency [Temporal Concept]
   753   C0871396:Frequency [Quantitative Concept]
   753   C1561548:Frequency [Qualitative Concept]
   753   C1705502:Frequency [Quantitative Concept]

Phrase: "in our study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "(0.19"

Phrase: ")"

Phrase: "was"

Phrase: "considerably higher than that"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C0205250:High [Qualitative Concept]
   737   C1299351:High [Qualitative Concept]
   737   C2700149:HIGH [Intellectual Product]

Phrase: "in the control group"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
  1000   C0009932:Control Group [Group]
   861   C0243148:control [Qualitative Concept]
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1550141:Control [Substance]
   861   C1552516:Group [Health Care Related Organization]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "of the previous report"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0684224:Report [Intellectual Product]
   861   C0700287:Report [Health Care Activity]
   861   C3273238:Report [Intellectual Product]

Phrase: "(0.09"

Phrase: ")"

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.50: It is unlikely that this difference reflects differing ethnic origins of our control and AD populations because the majority of controls were either unaffected spouses of AD subjects or were normal controls drawn from the same communities as the AD patients. 

Phrase: "It"

Phrase: "is"

Phrase: "unlikely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0750558:Unlikely [Conceptual Entity]
  1000   C1710571:Unlikely [Qualitative Concept]

Phrase: "that"

Phrase: "this difference"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1705241:*Difference [Quantitative Concept]
  1000   C1705242:Difference [Qualitative Concept]
   928 E C0443199:Differential [Qualitative Concept]

Phrase: "reflects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflect [Mental Process]

Phrase: "differing ethnic origins of our control"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0015031:Ethnic Origins [Population Group]
   753   C0079946:origins [Classification]
   753   C0439659:Origins [Temporal Concept]
   748   C0017263:genetic control [Genetic Function]
   737 E C0700589:Birth Control [Therapeutic or Preventive Procedure]
   719 E C1550512:origin [Intellectual Product]

Phrase: "and"

Phrase: "AD populations"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0032659:Population [Quantitative Concept]
   827   C1257890:Population [Population Group]
   734   C0002395:Alzheimer's Disease [Disease or Syndrome]
   734   C1521724:Alzheimer's Disease [Pathologic Function]

Phrase: "because"

Phrase: "the majority of controls"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0680220:majority [Social Behavior]

Phrase: "were"

Phrase: "either unaffected spouses of AD subjects"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   782   C2732307:Spouse of subject [Family Group]
   748   C0162409:Spouses [Family Group]

Phrase: "or"

Phrase: "were"

Phrase: "normal controls"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   966   C2705716:normal control [Qualitative Concept]
   861   C0205307:Normal [Qualitative Concept]
   861   C0439166:% normal [Quantitative Concept]
   861   C2347086:% Normal [Quantitative Concept]
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]

Phrase: "drawn from the same communities"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0009462:Communities [Geographic Area]
   760   C0445247:Same [Qualitative Concept]
   726   C0013113:Draw [Intellectual Product]

Phrase: "as the AD patients."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0030705:Patients [Patient or Disabled Group]
   734   C0002395:Alzheimer's Disease [Disease or Syndrome]
   734   C1521724:Alzheimer's Disease [Pathologic Function]
Processing 00000000.tx.51: Furthermore, two other studies of normal subjects have shown BCHE-K frequencies similar to those reported here (0.13-0.18) (1,3). 

Phrase: "Furthermore,"

Phrase: "two"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205448:Two [Quantitative Concept]

Phrase: "other studies of normal subjects"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   764   C0681850:Study Subject [Group]
   760   C0947630:studies [Laboratory Procedure]
   726 E C0557651:Study [Manufactured Object]
   726 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "BCHE-K frequencies"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0439603:Frequencies [Temporal Concept]
   827 E C0376249:frequency [Quantitative Concept]
   827 E C0871396:Frequency [Quantitative Concept]
   827 E C1561548:Frequency [Qualitative Concept]
   827 E C1705502:Frequency [Quantitative Concept]
   777 E C0332183:Frequent [Temporal Concept]

Phrase: "similar to those reported here"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2348205:Similar [Qualitative Concept]

Phrase: "(0.13-0.18"

Phrase: ")"

Phrase: "(1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")."
Processing 00000000.tx.52: One potential explanation for the failure to discover an allelic association between BCHE and AD is that the BCHE-K allele might be in weak linkage disequilibrium with a causative sequence change in another nearby gene. 

Phrase: "One potential explanation for the failure to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0681841:Explanation [Intellectual Product]

Phrase: "discover"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880355:Discover [Activity]

Phrase: "an allelic association between BCHE"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0004083:Association [Mental Process]
   760   C0439849:Association [Qualitative Concept]
   760   C0596306:Association [Phenomenon or Process]
   760   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "AD"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "is"

Phrase: "that"

Phrase: "the BCHE-K allele"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]

Phrase: "might"

Phrase: "be in weak linkage disequilibrium"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0023746:Linkage Disequilibrium [Quantitative Concept]
   760   C0004093:Weak [Sign or Symptom]
   760   C0023745:linkage [Molecular Function]
   760   C0281825:Disequilibrium [Finding]
   760   C0394006:Disequilibrium [Disease or Syndrome]
   760   C1762617:Weak [Qualitative Concept]
   760   C2987476:Be [Conceptual Entity]

Phrase: "with a causative sequence change"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0392747:Change [Functional Concept]
   827   C0443172:change [Quantitative Concept]
   827   C1705241:Change [Quantitative Concept]

Phrase: "in another nearby gene."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Gene [Gene or Genome]
Processing 00000000.tx.53: However, the segregation data in our FAD pedigrees using nearby anonymous, informative, microsatellite markers does not support this hypothesis because neither the maximum likelihood nor the non-parametric analyses detect any significant evidence for allele sharing amongst affected relatives. 

Phrase: "However,"

Phrase: "the segregation data in our FAD pedigrees"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1511726:Data [Idea or Concept]
   744   C3245479:data [Medical Device]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "nearby anonymous, informative, microsatellite markers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   840   C1519302:Microsatellite Markers [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   771   C0005516:Marker [Clinical Attribute]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "this hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "because"

Phrase: "neither the maximum likelihood"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   861   C0033204:Likelihood [Quantitative Concept]
   861   C0806909:Maximum [Quantitative Concept]
   861   C1552615:maximum [Quantitative Concept]
   861   C2826546:MAXIMUM [Quantitative Concept]
   789 E C0205289:Maximal [Qualitative Concept]
   789 E C0332148:Likely [Qualitative Concept]
   789 E C0750492:Likely [Idea or Concept]

Phrase: "nor"

Phrase: "the non-parametric analyses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0002778:Analysis [Laboratory Procedure]
   793   C0936012:Analysis [Research Activity]
   793   C1524024:analysis [Functional Concept]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "any significant evidence for allele sharing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0332120:Evidence [Functional Concept]

Phrase: "amongst affected relatives."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0080103:Relatives [Family Group]
   827 E C0205345:Relative [Qualitative Concept]
   827 E C1547039:*Relative [Quantitative Concept]
Processing 00000000.tx.54: Cumulatively, our data therefore argue for caution in the application of the BCHE-K variant in identification of elderly subjects who are at high risk of developing AD. 

Phrase: "Cumulatively,"

Phrase: "our data therefore"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "argue for caution"

Phrase: "in the application"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0185125:Application [Health Care Activity]
  1000   C1947919:Application [Intellectual Product]
  1000   C2347934:Application [Intellectual Product]
  1000   C3539080:APPLICATION [Quantitative Concept]

Phrase: "of the BCHE-K variant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205419:Variant [Qualitative Concept]

Phrase: "in identification"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0020792:Identification [Mental Process]
  1000   C0205396:Identification [Qualitative Concept]

Phrase: "of elderly subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0681850:Subject [Group]
   827   C1550501:{Subject} [Idea or Concept]
   827   C1706203:Subject [Idea or Concept]
   827   C2349001:Subject [Human]
   827   C2697811:Subject [Functional Concept]

Phrase: "who"

Phrase: "are at high risk of developing AD."
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   800   C0332167:High risk of [Qualitative Concept]
           High Risk
   770   C0002395:Alzheimer's Disease [Disease or Syndrome]
   770   C1521724:Alzheimer's Disease [Pathologic Function]
   770   C3272283:High Risk [Finding]
   767   C1281905:disease risk [Finding]
   744   C0012634:Disease [Disease or Syndrome]
   744   C0035647:Risk [Qualitative Concept]
   744   C0205250:High [Qualitative Concept]
   744   C1299351:High [Qualitative Concept]
   744   C1551058:Are [Quantitative Concept]
   744   C2700149:HIGH [Intellectual Product]
Processing 00000000.tx.55: MATERIALS AND METHODS A total of 138 subjects with sporadic AD diagnosed using NINCDS/ADRDA criteria and/or CERAD neuropathological criteria (128 probable AD; 10 definite AD) were collected from clinics specializing in memory disorders in Toronto or Miami (6-8). 

Phrase: "MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "A total of 138 subjects"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0439175:% total [Quantitative Concept]
   760   C0439810:Total [Qualitative Concept]

Phrase: "with sporadic AD"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   901   C0002395:Alzheimer's Disease [Disease or Syndrome]
   901   C1521724:Alzheimer's Disease [Pathologic Function]
   827   C0012634:Disease [Disease or Syndrome]
   827   C0205422:Sporadic [Temporal Concept]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]

Phrase: "diagnosed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0011900:Diagnosed [Finding]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "NINCDS/ADRDA criteria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0243161:criteria [Intellectual Product]

Phrase: "and/or"

Phrase: "CERAD neuropathological criteria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0243161:criteria [Intellectual Product]

Phrase: "(128 probable AD"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0002395:Alzheimer's Disease [Disease or Syndrome]
   861   C1521724:Alzheimer's Disease [Pathologic Function]
   812   C0012634:Disease [Disease or Syndrome]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]

Phrase: "; 10 definite AD"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0002395:Alzheimer's Disease [Disease or Syndrome]
   861   C1521724:Alzheimer's Disease [Pathologic Function]
   812   C0012634:Disease [Disease or Syndrome]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]

Phrase: ")"

Phrase: "were"

Phrase: "collected from clinics"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0442592:clinics [Health Care Related Organization,Manufactured Object]
   790   C1516695:Collected [Idea or Concept]
   790   C1516698:Collected [Functional Concept]
   756 E C0002424:Clinic [Health Care Related Organization,Manufactured Object]
   706 E C0205210:Clinical [Qualitative Concept]

Phrase: "specializing in memory disorders"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C0025261:Memory Disorders [Mental or Behavioral Dysfunction]
   770   C0012634:Disorders [Disease or Syndrome]
   770   C0025260:Memory [Mental Process]
   770   C0205555:specializing [Qualitative Concept]
   770   C0700327:memory [Finding]
   770   C1706377:Memory [Manufactured Object]
   715 E C0679055:mnemonic [Mental Process]

Phrase: "in Toronto"

Phrase: "or"

Phrase: "Miami"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551421:Miami [Population Group]

Phrase: "(6-8"

Phrase: ")."
Processing 00000000.tx.56: The 165 normal control subjects who had no evidence of neurologic disease were collected from the same sources, and were generally either spouses of AD-affected subjects, or were subjects specially recruited from the same communities to serve as normal controls. 

Phrase: "The 165 normal control subjects"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   861   C2705716:normal control [Qualitative Concept]
   812   C0205307:Normal [Qualitative Concept]
   812   C0243148:control [Qualitative Concept]
   812   C0439166:% normal [Quantitative Concept]
   812   C1550141:Control [Substance]
   812   C1882979:Control [Conceptual Entity]
   812   C2347086:% Normal [Quantitative Concept]
   812   C2587213:Control [Functional Concept]
   812   C3274648:Control [Qualitative Concept]
   779   C0681850:Subject [Group]
   779   C1550501:{Subject} [Idea or Concept]
   779   C1706203:Subject [Idea or Concept]
   779   C2349001:Subject [Human]
   779   C2697811:Subject [Functional Concept]

Phrase: "who"

Phrase: "had"

Phrase: "no evidence of neurologic disease"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   900   C1518340:No Evidence of Disease [Finding]
   806   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "were"

Phrase: "collected from the same sources,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0445247:Same [Qualitative Concept]
   760   C0449416:sources [Finding]
   760   C1516695:Collected [Idea or Concept]
   760   C1516698:Collected [Functional Concept]
   726 E C1705919:Source [Idea or Concept]

Phrase: "and"

Phrase: "were"

Phrase: "generally either spouses of AD-affected subjects,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   771   C2732307:Spouse of subject [Family Group]
   744   C0162409:Spouses [Family Group]

Phrase: "or"

Phrase: "were"

Phrase: "subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0681850:Subject [Group]
  1000   C1550501:{Subject} [Idea or Concept]
  1000   C1706203:Subject [Idea or Concept]
  1000   C2349001:Subject [Human]
  1000   C2697811:Subject [Functional Concept]

Phrase: "specially"

Phrase: "recruited from the same communities to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0009462:Communities [Geographic Area]
   753   C0445247:Same [Qualitative Concept]

Phrase: "serve as normal controls."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   799   C2705716:normal control [Qualitative Concept]
   770   C0205307:Normal [Qualitative Concept]
   770   C0439166:% normal [Quantitative Concept]
   770   C2347086:% Normal [Quantitative Concept]
   737   C0243148:control [Qualitative Concept]
   737   C1550141:Control [Substance]
   737   C1882979:Control [Conceptual Entity]
   737   C2587213:Control [Functional Concept]
   737   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.57: Fifty six FAD pedigrees with samples from at least three living AD-affected family members, and usually with AD in at least two contiguous generations, were collected from Caucasian families living in Europe or North America. 

Phrase: "Fifty six FAD pedigrees with samples"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0030761:pedigrees [Intellectual Product]

Phrase: "from"

Phrase: "at least three living AD-affected family members,"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   853   C2598516:Living family member [Clinical Attribute]
   822   C0344339:disease family [Finding]
   812   C0086282:Family Members [Family Group]
   793   C0015576:Family [Family Group]
   793   C0680022:members [Population Group]
   793   C1704727:Family [Conceptual Entity]
   779 E C1611821:Family Member [Intellectual Product]
   760 E C2698041:Member [Professional or Occupational Group]
   721 E C0241888:Familial [Functional Concept]

Phrase: "and"

Phrase: "usually with AD"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   833   C0002395:Alzheimer's Disease [Disease or Syndrome]
   833   C1521724:Alzheimer's Disease [Pathologic Function]
   770   C0012634:Disease [Disease or Syndrome]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: "in"

Phrase: "at least two contiguous generations,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0079411:Generations [Temporal Concept]
   779 E C3146294:Generation [Activity]
   712 E C1414672:Genesis [Gene or Genome]
   712 E C2984892:Genesis [Gene or Genome]

Phrase: "were"

Phrase: "collected from Caucasian families"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0007457:Caucasian [Population Group]
   770   C0015576:Families [Family Group]
   770   C0043157:Caucasian [Population Group]
   770   C1516695:Collected [Idea or Concept]
   770   C1516698:Collected [Functional Concept]
   770   C1704727:Family [Conceptual Entity]

Phrase: "living in Europe"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C0015176:Europe [Geographic Area]
   790   C0376558:Living [Idea or Concept]
   756 E C1548795:Live [Qualitative Concept]
   756 E C1634625:% live [Qualitative Concept]
   756 E C2982691:Live [Activity]

Phrase: "or"

Phrase: "North America."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0028405:North America [Geographic Area]
   928 E C0425358:NORTH AMERICAN [Finding]
   928 E C2700615:North American [Population Group]
   861   C0002454:America [Geographic Area]
   861   C1709269:North [Spatial Concept]
   789 E C0596070:American [Population Group]
Processing 00000000.tx.58: Mutations in PS1 (9), PS2 (10,11) or APP (12-14) previously have been excluded in these pedigrees. 

Phrase: "Mutations in PS1"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0026882:Mutations [Genetic Function]
   756 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "(9"

Phrase: ")"

Phrase: ","

Phrase: "PS2"

Phrase: "(10,"

Phrase: "11"

Phrase: ")"

Phrase: "or"

Phrase: "APP (12-14"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C3538722:APP [Laboratory Procedure]

Phrase: ")"

Phrase: "previously"

Phrase: "have"

Phrase: "been"

Phrase: "excluded in these pedigrees."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0030761:pedigrees [Intellectual Product]
   770   C1554077:Excluded [Idea or Concept]
   770   C2828389:Excluded [Activity]
   737 E C0332196:Exclude [Functional Concept]
Processing 00000000.tx.59: Genotypes at APOE were determined as previously described (5). 

Phrase: "Genotypes at APOE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0017431:Genotypes [Organism Attribute]

Phrase: "were"

Phrase: "determined as previously"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.60: The genotype at BCHE was determined using the method previously described (3), and also by ASO methods. 

Phrase: "The genotype at BCHE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0017431:Genotype [Organism Attribute]

Phrase: "was"

Phrase: "determined"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the method previously"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025663:Method [Intellectual Product]
   861   C0449851:Method [Functional Concept]
   861   C0871511:METHOD [Intellectual Product]

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "also by ASO methods."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0025663:Methods [Intellectual Product]
   770   C0025664:methods [Intellectual Product]
   770   C0449851:Methods [Functional Concept]
   737 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.61: Briefly, exon 4 of BCHE was amplified by PCR using the primers 1478, 5[prime]-TCA GTT AAT GAA ACA GAT AAA AAT, and 1479, 5[prime]-TAA GTT AAA GAT GTG AGG AAT CAA in a reaction volume of 10 l containing 100 ng of genomic DNA, 10 pmol of each primer 250 M dNTPs, 1.5 mM MgCl2 and 0.5 U of Taq polymerase, for 35 cycles of 94C for 20 s, 54C for 20 s and 72C for 20 s. 

Phrase: "Briefly,"

Phrase: "exon 4 of BCHE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0728810:Butyrylcholinesterase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C1412756:BUTYRYLCHOLINESTERASE [Gene or Genome]

Phrase: "was"

Phrase: "amplified by PCR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   790   C0677874:pCR [Finding]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the primers 1478,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "[prime"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0871133:prime [Functional Concept]

Phrase: "]-TCA GTT AAT GAA ACA GAT AAA AAT,"

Phrase: "and"

Phrase: "1479,"

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "[prime"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0871133:prime [Functional Concept]

Phrase: "]-TAA GTT AAA GAT GTG AGG AAT CAA in a reaction volume"

Phrase: "of 10 l"

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "100 ng of genomic DNA,"

Phrase: "10 pmol of each primer 250 M dNTPs,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0439192:pmol [Quantitative Concept]

Phrase: "1.5 mM MgCl2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0024472:MgCl2 [Inorganic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "0.5 U of Taq polymerase,"

Phrase: "for 35 cycles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1511572:Cycle [Temporal Concept]

Phrase: "of 94C"

Phrase: "for 20 s,"

Phrase: "54C for 20 s"

Phrase: "and"

Phrase: "72C for 20 s."
Processing 00000000.tx.62: The 331 bp PCR product was denatured in 100 l of 0.4 M NaOH, 25 mM EDTA, and slot-blotted to duplicate Hybond-N+ nylon membranes. 

Phrase: "The 331 bp PCR product"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1514468:product [Entity]
   812   C1704444:Product [Quantitative Concept]

Phrase: "was"

Phrase: "denatured in 100 l of 0.4 M NaOH,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   742   C0441923:M+ [Intellectual Product]

Phrase: "25 mM EDTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "slot-"

Phrase: "blotted"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "duplicate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205173:Duplicate [Functional Concept]
  1000   C3539942:Duplicate [Intellectual Product]

Phrase: "Hybond-N+ nylon membranes."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0025255:Membranes [Tissue]
   779 E C0596901:Membrane [Cell Component]
   779 E C1706182:Membrane [Manufactured Object]
   729 E C0205287:Membranous [Qualitative Concept]
Processing 00000000.tx.63: The ASOs 1480, 5[prime]-TAT TGA TGA AGC AGA ATG GGA (wild-type), and 1481, 5[prime]-TAT TGA TGA AAC AGA ATG GGA (BCHE-K) were end labelled and hybridized at 45C for 2 h in hybridization buffer (5 Denhardt's, 5 SSC, 0.5% SDS), washed to a final stringency of 2 SSC, 0.1% SDS at 58C, and then exposed to autoradiographic film. 

Phrase: "The ASOs 1480,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0002085:Allele [Gene or Genome]
   812   C0028953:Oligonucleotides [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0205369:Specific [Qualitative Concept]
   812   C1552740:specific [Intellectual Product]

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "[prime"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0871133:prime [Functional Concept]

Phrase: "]-TAT TGA TGA AGC AGA ATG GGA ("

Phrase: "wild-type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "1481,"

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "[prime"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0871133:prime [Functional Concept]

Phrase: "]-TAT TGA TGA AAC AGA ATG GGA (BCHE-K"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0728810:Butyrylcholinesterase [Amino Acid, Peptide, or Protein,Enzyme]
   793   C1412756:BUTYRYLCHOLINESTERASE [Gene or Genome]

Phrase: ")"

Phrase: "were"

Phrase: "end"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0444930:End [Spatial Concept]
  1000   C2746065:End [Temporal Concept]

Phrase: "labelled"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0181496:Label [Manufactured Object]
   966   C2827499:Label [Governmental or Regulatory Activity]

Phrase: "and"

Phrase: "hybridized at 45C"

Phrase: "for 2 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0011744:2 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "in hybridization buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "(5 Denhardt's,"

Phrase: "5 SSC,"

Phrase: "0.5% SDS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0444499:0/5 [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "washed to a final stringency of 2 SSC,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   744   C0205088:Final [Temporal Concept]
   744   C1546485:Final [Idea or Concept]
   744   C1548982:Washed [Idea or Concept]
   711 E C0441648:Wash [Activity]

Phrase: "0.1% SDS at 58C,"

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "exposed to autoradiographic film."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0332157:Exposed to [Clinical Attribute]
           Exposed
   770   C0086296:Film [Manufactured Object]
   770   C1561571:film [Biomedical or Dental Material]
   770   C1561572:film [Substance]
Processing 00000000.tx.64: The primer sequences and PCR conditions for the anonymous markers D3S1744 and D3S1763 were obtained from the Genome Database. 

Phrase: "The primer sequences"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0162326:Sequences [Nucleotide Sequence]
   827 E C0004793:Sequence [Nucleotide Sequence]
   827 E C0162327:Sequence [Nucleotide Sequence]
   827 E C1519249:Sequence [Functional Concept]
   777 E C1548958:Sequential [Idea or Concept]
   777 E C1705294:Sequential [Qualitative Concept]

Phrase: "and"

Phrase: "PCR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
  1000   C0677874:pCR [Finding]

Phrase: "conditions for the anonymous markers D3S1744"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0012634:condition [Disease or Syndrome]
   753   C0348080:Condition [Qualitative Concept]
   753   C1705253:Condition [Conceptual Entity]
   753   C2346787:Anonymous [Qualitative Concept]
   753   C3245483:Anonymous [Intellectual Product]
   719   C0005516:Marker [Clinical Attribute]

Phrase: "and"

Phrase: "D3S1763"

Phrase: "were"

Phrase: "obtained from the Genome Database."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   806   C0872346:genome database [Intellectual Product]
   760   C0017428:Genome [Gene or Genome]
   760   C0242356:Database [Intellectual Product]
   760   C0993637:Data Base [Intellectual Product]
   760   C1301820:Obtained [Functional Concept]
   760   C2338314:Genome [Conceptual Entity]
   726 E C1706701:Obtain [Activity]
Processing 00000000.tx.65: A [chi]2 test was used to compare BCHE allele frequencies between unrelated AD, FAD and control cases. 

Phrase: "A [chi]2 test"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0022885:Test [Laboratory Procedure]
   812   C0039593:Test [Functional Concept]
   812   C0392366:test [Intellectual Product]
   708   C1825406:A-2 [Gene or Genome]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "compare"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compare [Activity]

Phrase: "BCHE allele frequencies between unrelated AD,"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   778   C0017270:Frequencies, Allele [Quantitative Concept]
   748   C0439603:Frequencies [Temporal Concept]
   714 E C0376249:frequency [Quantitative Concept]
   714 E C0871396:Frequency [Quantitative Concept]
   714 E C1561548:Frequency [Qualitative Concept]
   714 E C1705502:Frequency [Quantitative Concept]

Phrase: "FAD"

Phrase: "and"

Phrase: "control cases."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   861   C0243148:control [Qualitative Concept]
   861   C0868928:Cases [Functional Concept]
   861   C1533148:Cases [Quantitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
   827 E C1706255:CASE [Medical Device]
   827 E C1706256:Case [Conceptual Entity]
Processing 00000000.tx.66: The Fisher's exact test was used to compare APOE genotypes. 

Phrase: "The Fisher's exact test"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C1708064:Fisher's Exact Test [Intellectual Product]
           Fisher's Test
   827   C0022885:Test [Laboratory Procedure]
   827   C0039593:Test [Functional Concept]
   827   C0325045:Fisher [Mammal]
   827   C0392366:test [Intellectual Product]
   827   C2828393:Exact [Qualitative Concept]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "compare"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compare [Activity]

Phrase: "APOE genotypes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0017431:Genotypes [Organism Attribute]
   734   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.67: The influence of BCHE and APOE genotypes, age group and sex on the odds of developing AD was assessed using logistic regression procedures (4). 

Phrase: "The influence of BCHE"

Phrase: "and"

Phrase: "APOE genotypes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0017431:Genotypes [Organism Attribute]
   734   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "age group"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0027362:Age Group [Age Group]
  1000   C2348001:Age Group [Population Group]
   861   C0001779:Age [Organism Attribute]
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: "and"

Phrase: "sex on the odds of developing AD"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   744   C0009253:Sex [Organism Function]
   744   C0036864:Sex [Behavior]
   744   C0079399:sex [Organism Attribute]
   744   C1314687:Sex [Finding]
   744   C1522384:sex [Organism Attribute]

Phrase: "was"

Phrase: "assessed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assessed [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "logistic regression procedures"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   827   C0025664:procedures [Intellectual Product]
   827   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   827   C2700391:procedures [Activity]
   793 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   793 E C3274430:PROCEDURE [Health Care Activity]
   793 E C3538935:Procedure [Idea or Concept]
   793 E C3539779:Procedure [Intellectual Product]
   734   C0206031:Logistic Regression [Research Activity]

Phrase: "(4"

Phrase: ")."
Processing 00000000.tx.68: To accommodate polychotomous classification of the genetic loci in regression analysis, indicator variables were constructed representing two BCHE genotype classes (K/W and K/K) and two APOE genotype classes (2/2 or 2/3; and 2/4, 3/4 or 4/4). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "accommodate"

Phrase: "polychotomous classification of the genetic loci"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0008902:Classification [Classification]
   753   C0008903:classification [Functional Concept]
   753   C0678229:classification [Occupational Activity]

Phrase: "in regression analysis,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0034980:Regression Analysis [Intellectual Product]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0684320:Regression [Pathologic Function]
   861   C0684321:Regression [Mental Process]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "indicator variables"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439828:variables [Qualitative Concept]

Phrase: "were"

Phrase: "constructed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2827421:Construct [Classification]

Phrase: "representing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1882932:Represent [Activity]

Phrase: "two BCHE genotype classes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0456387:Class [Intellectual Product]
   812   C1705943:Class [Classification]

Phrase: "(K/W"

Phrase: "and"

Phrase: "K/K)"

Phrase: "and"

Phrase: "two APOE genotype classes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0456387:Class [Intellectual Product]
   804   C1705943:Class [Classification]

Phrase: "(2/2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0740116:+2 [Quantitative Concept]
   861   C2827735:2+ [Quantitative Concept]
   861   C2981700:2+ [Classification]

Phrase: "or"

Phrase: "2/3"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1519042:2-3 [Research Activity]
   861   C0740116:+2 [Quantitative Concept]
   861   C2827735:2+ [Quantitative Concept]
   861   C2981700:2+ [Classification]

Phrase: ";"

Phrase: "and"

Phrase: "2/4,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0740116:+2 [Quantitative Concept]
   861   C2827735:2+ [Quantitative Concept]
   861   C2981700:2+ [Classification]

Phrase: "3/4"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0442757:3 4 [Finding]
   861   C0439086:<3 [Quantitative Concept]
   861   C2827736:3+ [Quantitative Concept]
   861   C2981702:3+ [Classification]

Phrase: "or"

Phrase: "4/4"

Phrase: ")."
Processing 00000000.tx.69: These variables took on the value of `1' if the subject had the corresponding genotype, and `0' otherwise. 

Phrase: "These variables"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439828:variables [Qualitative Concept]

Phrase: "took on the value of `1'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1522609:Value [Quantitative Concept]
   719   C1515187:Take [Health Care Activity]

Phrase: "if"

Phrase: "the subject"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0681850:Subject [Group]
  1000   C1550501:{Subject} [Idea or Concept]
  1000   C1706203:Subject [Idea or Concept]
  1000   C2349001:Subject [Human]
  1000   C2697811:Subject [Functional Concept]

Phrase: "had"

Phrase: "the corresponding genotype,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017431:Genotype [Organism Attribute]

Phrase: "and `"

Phrase: "0' otherwise."
Processing 00000000.tx.70: According to this scheme, BCHE-W/W and APOE-3/3 genotypes were considered as the referents. 

Phrase: "According to this scheme,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1519193:Scheme [Intellectual Product]

Phrase: "BCHE-W/W"

Phrase: "and"

Phrase: "APOE-3/3 genotypes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0017431:Genotypes [Organism Attribute]
   717   C0052199:Apolipoprotein E-3 [Amino Acid, Peptide, or Protein]

Phrase: "were"

Phrase: "considered as the referents."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0750591:considered [Idea or Concept]
   737   C1706462:Referent [Conceptual Entity]
Processing 00000000.tx.71: Interaction between BCHE, APOE, age and sex was evaluated by deriving product terms for each genotype with each other, age group and sex. 

Phrase: "Interaction between BCHE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1704675:Interaction [Functional Concept]

Phrase: "APOE,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003595:Apolipoprotein E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "age"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "and"

Phrase: "sex"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0009253:Sex [Organism Function]
  1000   C0036864:Sex [Behavior]
  1000   C0079399:sex [Organism Attribute]
  1000   C1314687:Sex [Finding]
  1000   C1522384:sex [Organism Attribute]

Phrase: "was"

Phrase: "evaluated by deriving product terms"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0220825:Evaluated [Functional Concept]
   760   C1514468:product [Entity]
   760   C1704444:Product [Quantitative Concept]
   760   C1711343:Deriving [Qualitative Concept]
   726   C1515273:Term [Temporal Concept]
   726   C1705313:Term [Idea or Concept]
   726   C2826302:TERM [Intellectual Product]

Phrase: "for each genotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017431:Genotype [Organism Attribute]

Phrase: "with each other,"

Phrase: "age group"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0027362:Age Group [Age Group]
  1000   C2348001:Age Group [Population Group]
   861   C0001779:Age [Organism Attribute]
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: "and"

Phrase: "sex."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0009253:Sex [Organism Function]
  1000   C0036864:Sex [Behavior]
  1000   C0079399:sex [Organism Attribute]
  1000   C1314687:Sex [Finding]
  1000   C1522384:sex [Organism Attribute]
Processing 00000000.tx.72: Models were evaluated using the LOGISTIC procedure in SAS (15). 

Phrase: "Models"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3161035:Models [Intellectual Product]

Phrase: "were"

Phrase: "evaluated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluated [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the LOGISTIC procedure in SAS (15"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0184661:Procedure [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   753   C1948041:Procedure [Therapeutic or Preventive Procedure]
   753   C2700391:Procedure [Activity]
   753   C3274430:PROCEDURE [Health Care Activity]
   753   C3538935:Procedure [Idea or Concept]
   753   C3539779:Procedure [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.73: Comparisons of the relative fit of hierarchical models were carried out by computing the difference in the -2 ln likelihoods for the models, which follows a [chi]2 distribution. 

Phrase: "Comparisons of the relative fit of hierarchical models"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   711   C1707455:Comparison [Activity]

Phrase: "were"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out by computing"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0439787:Out [Spatial Concept]
   790   C0849355:Out [Qualitative Concept]
   790   C1880157:Computing [Activity]

Phrase: "the difference in the -2 ln likelihoods"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1705241:*Difference [Quantitative Concept]
   748   C1705242:Difference [Qualitative Concept]

Phrase: "for the models,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3161035:Models [Intellectual Product]

Phrase: "which"

Phrase: "follows"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332283:follow [Temporal Concept]
  1000   C1719822:Follow [Intellectual Product]

Phrase: "a [chi]2 distribution."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0520511:distribution [Idea or Concept]
   812   C1704711:Distribution [Functional Concept]
   708   C1825406:A-2 [Gene or Genome]
Processing 00000000.tx.74: The hypothesis for the existence of an AD gene adjacent to BCHE was evaluated by multilocus linkage analysis in 56 FAD pedigrees. 

Phrase: "The hypothesis for the existence of an AD gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C1512571:Hypothesis [Idea or Concept]

Phrase: "adjacent to BCHE"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   882   C0205117:Adjacent to [Spatial Concept]
           Adjacent
   718 E C3242705:adjacency [Idea or Concept]

Phrase: "was"

Phrase: "evaluated by multilocus linkage analysis"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0796345:linkage analysis [Laboratory Procedure]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0023745:linkage [Molecular Function]
   760   C0220825:Evaluated [Functional Concept]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]

Phrase: "in 56 FAD pedigrees."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0030761:pedigrees [Intellectual Product]
Processing 00000000.tx.75: Linkage to the interval between D3S1744 and D3S1763 was tested using the GENEHUNTER program (16). 

Phrase: "Linkage to the interval"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0023745:linkage [Molecular Function]

Phrase: "between D3S1744"

Phrase: "and"

Phrase: "D3S1763"

Phrase: "was"

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the GENEHUNTER program"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1709697:Program [Conceptual Entity]
   861   C2728259:Program [Pharmacologic Substance]
   861   C3484370:Program [Functional Concept]

Phrase: "(16"

Phrase: ")."
Processing 00000000.tx.76: Marker allele frequencies were obtained from the Genome Database. 

Phrase: "Marker allele frequencies"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
   901   C0017270:Frequencies, Allele [Quantitative Concept]
   827   C0439603:Frequencies [Temporal Concept]
   793 E C0376249:frequency [Quantitative Concept]
   793 E C0871396:Frequency [Quantitative Concept]
   793 E C1561548:Frequency [Qualitative Concept]
   793 E C1705502:Frequency [Quantitative Concept]
   743 E C0332183:Frequent [Temporal Concept]

Phrase: "were"

Phrase: "obtained from the Genome Database."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   806   C0872346:genome database [Intellectual Product]
   760   C0017428:Genome [Gene or Genome]
   760   C0242356:Database [Intellectual Product]
   760   C0993637:Data Base [Intellectual Product]
   760   C1301820:Obtained [Functional Concept]
   760   C2338314:Genome [Conceptual Entity]
   726 E C1706701:Obtain [Activity]
Processing 00000000.tx.77: For parametric analyses, AD was modelled as an autosomal dominant trait with a mutant allele frequency of 0.001. 

Phrase: "For parametric analyses,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "AD"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "was"

Phrase: "modelled as an autosomal dominant trait"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0178491:autosomal dominant trait [Organism Attribute]
   790   C0443147:Autosomal dominant [Intellectual Product]
   753   C0596142:autosomal [Cell Component]
   753   C0599883:Trait [Organism Attribute]
   753   C1527180:Dominant [Functional Concept]
   719   C3161035:Model [Intellectual Product]

Phrase: "with a mutant allele frequency"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   901   C0017270:Allele Frequency [Quantitative Concept]
   827   C0376249:frequency [Quantitative Concept]
   827   C0439603:Frequency [Temporal Concept]
   827   C0871396:Frequency [Quantitative Concept]
   827   C1561548:Frequency [Qualitative Concept]
   827   C1705502:Frequency [Quantitative Concept]
   755 E C0332183:Frequent [Temporal Concept]

Phrase: "of 0.001."
Processing 00000000.tx.78: Replication using a disease allele frequency of 0.01 gave similar results. 

Phrase: "Replication"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0598312:Replication [Genetic Function]
  1000   C1883725:replication [Qualitative Concept]
   928 E C0205173:Replicate [Functional Concept]
   928 E C0205341:Replicate [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a disease allele frequency of 0.01"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C0017270:Allele Frequency [Quantitative Concept]
   748   C0376249:frequency [Quantitative Concept]
   748   C0439603:Frequency [Temporal Concept]
   748   C0871396:Frequency [Quantitative Concept]
   748   C1561548:Frequency [Qualitative Concept]
   748   C1705502:Frequency [Quantitative Concept]

Phrase: "gave"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1947971:Give [Functional Concept]

Phrase: "similar results."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]
Processing 00000000.tx.79: Age- and sex-dependent penetrance was defined as a step function based on 17 age intervals derived from censored data analyses for early-onset (family mean onset age <65 years) and late-onset (family mean onset age >65 years) families (17,18). 

Phrase: "Age-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "and"

Phrase: "sex-dependent penetrance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0524899:Penetrance [Quantitative Concept]

Phrase: "was"

Phrase: "defined as a step function"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   760   C0031843:function [Physiologic Function]
   760   C0542341:Function [Functional Concept]
   760   C0700205:FUNCTION [Classification]
   760   C1261552:Step [Conceptual Entity]
   760   C1704379:Step [Functional Concept]
   760   C1704788:Defined [Conceptual Entity]
   760   C1705117:Step [Quantitative Concept]
   760   C1705273:Function [Intellectual Product]
   760   C2825408:Step [Manufactured Object]
   760   C3539106:Defined [Intellectual Product]

Phrase: "based on 17 age intervals"
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   760   C0001779:Age [Organism Attribute]
   760   C1272706:intervals [Temporal Concept]
   760   C1527178:Based [Functional Concept]
   760   C1705938:Based [Idea or Concept]
   726 E C0002055:base [Inorganic Chemical]
   726 E C0178499:Base [Chemical Viewed Functionally]
   726 E C1552654:Interval [Idea or Concept]
   726 E C1552713:Interval [Intellectual Product]
   726 E C1880279:Base [Biomedical or Dental Material]

Phrase: "derived from censored data analyses"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   806   C0010992:Data Analyses [Occupational Activity]
   797   C0868941:Derived Data [Machine Activity]
   760   C1441547:Derived [Qualitative Concept]
   760   C1511726:Data [Idea or Concept]
   760   C3245479:data [Medical Device]
   760   C3245521:derived [Idea or Concept]
   726   C0002778:Analysis [Laboratory Procedure]
   726   C0936012:Analysis [Research Activity]
   726   C1524024:analysis [Functional Concept]

Phrase: "for early-onset"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1833334:Early-onset [Finding]
   861   C0332162:Onset [Qualitative Concept]
   861   C1279919:Early [Temporal Concept]

Phrase: "(family mean onset age <65 years"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   839   C1510829:Age-Years [Temporal Concept]
   799   C0439234:years [Temporal Concept]
   766 E C0439508:/year [Temporal Concept]

Phrase: ")"

Phrase: "and"

Phrase: "late-onset"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205087:Late [Temporal Concept]
   861   C0332162:Onset [Qualitative Concept]

Phrase: "(family mean onset age >65 years"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   839   C1510829:Age-Years [Temporal Concept]
   799   C0439234:years [Temporal Concept]
   766 E C0439508:/year [Temporal Concept]

Phrase: ")"

Phrase: "families"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015576:Families [Family Group]
  1000   C1704727:Family [Conceptual Entity]
   916 E C0241888:Familial [Functional Concept]

Phrase: "(17,"

Phrase: "18"

Phrase: ")."
Processing 00000000.tx.80: A second set of analyses were carried out by assigning a constant low penetrance (0.02) to all unaffected at-risk individuals. 

Phrase: "A second"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0205436:Second [Quantitative Concept]
  1000   C0457385:Second [Temporal Concept]
  1000   C0565930:/second [Quantitative Concept]
  1000   C1561503:second [Idea or Concept]
  1000   C1705190:Second [Qualitative Concept]
   928 E C0027627:secondary [Neoplastic Process]
   928 E C0175668:Secondary [Temporal Concept]

Phrase: "set of analyses"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0036849:Set [Mental Process]
   790   C1442518:Set [Functional Concept]
   790   C1705195:Set [Conceptual Entity]
   756   C0002778:Analysis [Laboratory Procedure]
   756   C0936012:Analysis [Research Activity]
   756   C1524024:analysis [Functional Concept]

Phrase: "were"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out by assigning"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0439787:Out [Spatial Concept]
   790   C0849355:Out [Qualitative Concept]
   756   C1516050:Assign [Functional Concept]

Phrase: "a constant low penetrance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0524899:Penetrance [Quantitative Concept]

Phrase: "(0.02"

Phrase: ")"

Phrase: "to all unaffected at-risk individuals."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C0027361:Individual [Population Group]
   779   C0237401:Individual [Human]
Processing 00000000.tx.81: This represents a conservative `affecteds-only' model where unaffected individuals provide minimal information with regard to the disease but are important for linkage phase determination with respect to marker data. 

Phrase: "This"

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "a conservative `affecteds-only' model where unaffected individuals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   762   C0027361:Individual [Population Group]
   762   C0237401:Individual [Human]

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "minimal information with regard to the disease"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1533716:Information [Idea or Concept]

Phrase: "but"

Phrase: "are"

Phrase: "important for linkage phase determination"

Phrase: "with respect to marker data."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]
Processing 00000000.tx.82: The possibility of linkage in the presence of heterogeneity was assessed using Smith's admixture test implemented in the HOMOG program (19). 

Phrase: "The possibility of linkage"

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of heterogeneity"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0019409:Heterogeneity [Qualitative Concept]
   916 E C1512426:Heterogenous [Idea or Concept]

Phrase: "was"

Phrase: "assessed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assessed [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Smith's admixture test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0022885:Test [Laboratory Procedure]
   827   C0039593:Test [Functional Concept]
   827   C0392366:test [Intellectual Product]

Phrase: "implemented in the HOMOG program"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1709697:Program [Conceptual Entity]
   760   C2728259:Program [Pharmacologic Substance]
   760   C3484370:Program [Functional Concept]

Phrase: "(19"

Phrase: ")."
Processing 00000000.tx.83: Comparison of the null hypothesis of no linkage (H0) and the alternate hypothesis of linkage with heterogeneity (Ha; [alpha] <1) for the location scores was carried out as a likelihood ratio test with P values calculated from the asymptotic [chi]2 distribution with two degrees of freedom. 

Phrase: "Comparison of the null hypothesis of no linkage"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1707455:Comparison [Activity]

Phrase: "(H0"

Phrase: ")"

Phrase: "and"

Phrase: "the alternate hypothesis of linkage"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1512571:Hypothesis [Idea or Concept]

Phrase: "with heterogeneity"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0019409:Heterogeneity [Qualitative Concept]
   916 E C1512426:Heterogenous [Idea or Concept]

Phrase: "(Ha"

Phrase: ";"

Phrase: "[alpha] <1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1879647:Alpha1 [Qualitative Concept]
  1000   C1979844:Alpha 1 [Amino Acid, Peptide, or Protein]
   861   C0439095:Alpha [Intellectual Product]
   861   C2003941:Alpha [Intellectual Product]
   861   C2350010:Alpha [Qualitative Concept]

Phrase: ")"

Phrase: "for the location scores"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449820:Scores [Quantitative Concept]

Phrase: "was"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out as a likelihood ratio test"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C0150102:LIKELIHOOD RATIO [Quantitative Concept]
   753   C0022885:Test [Laboratory Procedure]
   753   C0033204:Likelihood [Quantitative Concept]
   753   C0039593:Test [Functional Concept]
   753   C0392366:test [Intellectual Product]
   753   C0439787:Out [Spatial Concept]
   753   C0456603:Ratio [Quantitative Concept]
   753   C0849355:Out [Qualitative Concept]
   753   C1547037:Ratio [Intellectual Product]

Phrase: "with P values"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C1709380:P-Value [Quantitative Concept]
   861   C0042295:Values [Qualitative Concept]
   827 E C1522609:Value [Quantitative Concept]

Phrase: "calculated from the asymptotic"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0444686:Calculated [Functional Concept]
   770   C1441506:Calculated [Activity]
   770   C1443182:Calculated [Laboratory Procedure]

Phrase: "[chi]2 distribution with two degrees of freedom."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0520511:distribution [Idea or Concept]
   744   C1704711:Distribution [Functional Concept]
Processing 00000000.tx.84: Families having fewer than two informative meioses were excluded from the test. 

Phrase: "Families"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015576:Families [Family Group]
  1000   C1704727:Family [Conceptual Entity]
   916 E C0241888:Familial [Functional Concept]

Phrase: "having"

Phrase: "fewer than two informative meioses"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C0205388:Few [Quantitative Concept]

Phrase: "were"

Phrase: "excluded from the test."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0022885:Test [Laboratory Procedure]
   770   C0039593:Test [Functional Concept]
   770   C0392366:test [Intellectual Product]
   770   C1554077:Excluded [Idea or Concept]
   770   C2828389:Excluded [Activity]
   737 E C0332196:Exclude [Functional Concept]
Processing 00000000.tx.85: Linkage data were also evaluated using a non-parametric approach implemented in GENEHUNTER. 

Phrase: "Linkage data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "were"

Phrase: "also"

Phrase: "evaluated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluated [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a non-parametric approach"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0449445:Approach [Spatial Concept]

Phrase: "implemented in GENEHUNTER."
Processing 00000000.tx.86: ACKNOWLEDGEMENTS This work was supported through grants from the Medical Research Council of Canada, The Canadian Genetic Diseases Network, The Alzheimer Association of Ontario, The Howard Hughes Medical Research Foundation, the EJLB Foundation, the National Institutes of Health (AG09029), the Peter Burgess Fellowship (E.A.R.), the Alzheimer Society of Canada Fellowship (G.L.), the Helen B. 

Phrase: "ACKNOWLEDGEMENTS"

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "supported through grants"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0018173:Grants [Quantitative Concept]
   790   C1521721:Supported [Conceptual Entity]
   756 E C0183683:Support [Medical Device]
   756 E C1548284:Grant [Idea or Concept]

Phrase: "from the Medical Research Council"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0079816:Medical Research [Research Activity]
   901   C1556038:Medical Research [Professional or Occupational Group]
   827   C0035168:research [Research Activity]
   827   C0205476:Medical [Functional Concept]
   827   C0242481:Research [Research Activity]
   827   C1551807:Council [Population Group]

Phrase: "of Canada,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006823:Canada [Geographic Area]

Phrase: "The Canadian Genetic Diseases Network,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1513822:Network [Professional or Occupational Group]
   812   C1705739:Network [Manufactured Object]
   812   C1882071:Network [Conceptual Entity]

Phrase: "The Alzheimer Association of Ontario,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0004083:Association [Mental Process]
   760   C0439849:Association [Qualitative Concept]
   760   C0596306:Association [Phenomenon or Process]
   760   C0699792:association [Social Behavior]

Phrase: "The Howard Hughes Medical Research Foundation,"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   804   C0016617:Foundation [Organization]
   798   C2986512:Research Base [Organization]
   721 E C0002055:base [Inorganic Chemical]
   721 E C0178499:Base [Chemical Viewed Functionally]
   721 E C1626935:Bases [Quantitative Concept]
   721 E C1880279:Base [Biomedical or Dental Material]

Phrase: "the EJLB Foundation,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0016617:Foundation [Organization]
   777 E C0002055:base [Inorganic Chemical]
   777 E C0178499:Base [Chemical Viewed Functionally]
   777 E C1626935:Bases [Quantitative Concept]
   777 E C1880279:Base [Biomedical or Dental Material]
   755 E C0205112:Basal [Spatial Concept]

Phrase: "the National Institutes of Health"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027468:National Institutes of Health [Health Care Related Organization]
           national institute health
   812   C0018684:Health [Idea or Concept]
   812   C0021622:Institutes [Organization]
   812   C3245503:national [Intellectual Product]
   779 E C1272753:Institute [Idea or Concept]
   712 E C0031206:healthiness [Finding]

Phrase: "(AG09029"

Phrase: ")"

Phrase: ","

Phrase: "the Peter Burgess Fellowship"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0015770:Fellowship [Educational Activity]

Phrase: "(E.A.R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205090:R- [Spatial Concept]
   827   C0684010:R. [Professional or Occupational Group]
   827   C2603358:R' [Clinical Attribute]

Phrase: ")"

Phrase: ","

Phrase: "the Alzheimer Society of Canada Fellowship"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0037455:society [Organization]

Phrase: "(G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "the Helen B."
Processing 00000000.tx.87: Hunter Fellowship (G.Y.), the National Institutes of Health (T32-AG00115) (S.P.) and the Medical Research Council of Canada (A.P.). 

Phrase: "Hunter Fellowship"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015770:Fellowship [Educational Activity]

Phrase: "(G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Y."

Phrase: ")"

Phrase: ","

Phrase: "the National Institutes of Health"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027468:National Institutes of Health [Health Care Related Organization]
           national institute health
   812   C0018684:Health [Idea or Concept]
   812   C0021622:Institutes [Organization]
   812   C3245503:national [Intellectual Product]
   779 E C1272753:Institute [Idea or Concept]
   712 E C0031206:healthiness [Finding]

Phrase: "(T32-AG00115"

Phrase: ")"

Phrase: "("

Phrase: "S.P."

Phrase: ")"

Phrase: "and"

Phrase: "the Medical Research Council of Canada"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0079816:Medical Research [Research Activity]
   790   C1556038:Medical Research [Professional or Occupational Group]
   753   C0035168:research [Research Activity]
   753   C0205476:Medical [Functional Concept]
   753   C0242481:Research [Research Activity]
   753   C1551807:Council [Population Group]

Phrase: "(A.P."

Phrase: ")."
Processing 00000000.tx.88: REFERENCES 1. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.89: Bartels, C.F., Jensen, F.S., Lockridge, O., van der Spek, A.F.L., Rubinstein, H.M., Lubrano, T. and La Du, B.N. 

Phrase: "Bartels,"

Phrase: "C.F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Jensen,"

Phrase: "F.S.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Lockridge,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "van der Spek,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557775:Van [Manufactured Object]
   827   C1511780:der [Cell or Molecular Dysfunction]

Phrase: "A.F.L., Rubinstein,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "M."

Phrase: ","

Phrase: "Lubrano,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "La Du,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540681:DU [Idea or Concept]

Phrase: "B.N."
Processing 00000000.tx.90: (1992) DNA mutation associated with the butyrylcholinesterase K-variant and its linkage to the atypical variant mutation and other polymorphic sites. 

Phrase: "(1992"

Phrase: ")"

Phrase: "DNA mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0026882:Mutation [Genetic Function]
   861   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "associated with the butyrylcholinesterase K-variant"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   790   C0332281:Associated with [Qualitative Concept]
           Associated
   753   C0205419:Variant [Qualitative Concept]
   753   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   753   C0728810:Butyrylcholinesterase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C1412756:BUTYRYLCHOLINESTERASE [Gene or Genome]
   753   C1708601:K' [Quantitative Concept]
   719 E C0750490:Associate [Idea or Concept]
   719 E C1706221:Associate [Professional or Occupational Group]

Phrase: "and"

Phrase: "its linkage to the atypical variant mutation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0023745:linkage [Molecular Function]

Phrase: "and"

Phrase: "other polymorphic sites."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0205145:Sites [Spatial Concept]
   827 E C1515974:Site [Body Location or Region]
   827 E C2825164:Site [Spatial Concept]
Processing 00000000.tx.91: Am. 

Phrase: "Am."
Processing 00000000.tx.92: J. 

Phrase: "J."
Processing 00000000.tx.93: Hum. 

Phrase: "Hum."
Processing 00000000.tx.94: Genet., 50, 1086-1103. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "50,"

Phrase: "1086-1103."
Processing 00000000.tx.95: MEDLINE Abstract 2. 

Phrase: "MEDLINE Abstract 2."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.96: Lehmann, D.J., Johnston, C. and Smith, A.D. 

Phrase: "Lehmann,"

Phrase: "D.J.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Johnston,"

Phrase: "C."

Phrase: "and"

Phrase: "Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "A.D."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0718133:a & d [Organic Chemical,Pharmacologic Substance,Vitamin]
Processing 00000000.tx.97: (1997) Synergy between the genes for butyrylcholinesterase K variant and apolipoprotein E4 in late onset confirmed Alzheimer disease. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Synergy between the genes"

Phrase: "for butyrylcholinesterase K variant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205419:Variant [Qualitative Concept]

Phrase: "and"

Phrase: "apolipoprotein E4 in late onset"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0052201:Apolipoprotein E-4 [Amino Acid, Peptide, or Protein]
   760   C0003591:Apolipoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "Alzheimer disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.98: Hum. 

Phrase: "Hum."
Processing 00000000.tx.99: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.100: Genet., 6, 1933-1936. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "6,"

Phrase: "1933-1936."
Processing 00000000.tx.101: MEDLINE Abstract 3. 

Phrase: "MEDLINE Abstract 3."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.102: Jensen, F.S., Nielsen, L.R. and Schwartz, M. 

Phrase: "Jensen,"

Phrase: "F.S.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Nielsen,"

Phrase: "L.R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Schwartz,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.103: (1996) Detection of the plasma cholinesterase K variant by PCR using an amplification-created restriction site. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Detection of the plasma cholinesterase K variant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "by PCR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
  1000   C0677874:pCR [Finding]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an amplification-created restriction site."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C1882940:Restriction Site [Nucleotide Sequence]
   812   C0205145:Site [Spatial Concept]
   812   C0443288:Restriction [Functional Concept]
   812   C1515974:Site [Body Location or Region]
   812   C2825164:Site [Spatial Concept]
Processing 00000000.tx.104: Hum. 

Phrase: "Hum."
Processing 00000000.tx.105: Hered., 46, 26-31. 

Phrase: "Hered.,"

Phrase: "46,"

Phrase: "26-31."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450355:31 [Intellectual Product]
Processing 00000000.tx.106: MEDLINE Abstract 4. 

Phrase: "MEDLINE Abstract 4."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.107: Breslow, N.E. and Day, N.E. 

Phrase: "Breslow,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1511325:Breslow [Clinical Attribute]

Phrase: "N.E."

Phrase: "and"

Phrase: "Day,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332173:/day [Temporal Concept]
  1000   C0439228:day [Temporal Concept]
  1000   C0439505:/day [Temporal Concept]

Phrase: "N.E."
Processing 00000000.tx.108: (1980) The Analysis of Case Control Studies. 

Phrase: "(1980"

Phrase: ")"

Phrase: "The Analysis of Case Control Studies."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]
Processing 00000000.tx.109: Statistical Methods in Cancer Research, Vol. 

Phrase: "Statistical Methods in Cancer Research,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   797   C0086912:Research Methods [Research Activity]
   790   C1710191:Statistical Method [Research Activity]
   760   C0025663:Methods [Intellectual Product]
   760   C0025664:methods [Intellectual Product]
   760   C0449851:Methods [Functional Concept]
   726 E C0871511:METHOD [Intellectual Product]

Phrase: "Vol."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0449468:VOL [Quantitative Concept]
  1000   C0560268:vol% [Quantitative Concept]
  1000   C1690016:% vol [Qualitative Concept]
Processing 00000000.tx.110: 1. 

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.111: Lyon: IARC Scientific Publications 32. 

Phrase: "Lyon"

Phrase: ":"

Phrase: "IARC Scientific Publications 32."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C1704324:Scientific Publications [Intellectual Product]
       E   Publication
   812   C0034036:Publications [Intellectual Product,Manufactured Object]
   812   C0036397:Scientific [Occupation or Discipline]
   812   C1512889:IARC [Health Care Related Organization]
   779 E C0034037:Publication [Occupational Activity]
Processing 00000000.tx.112: 5. 

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.113: Saunders, A., Strittmatter, W.J., Schmechel, S. et al). 

Phrase: "Saunders,"

Phrase: "A.,"

Phrase: "Strittmatter,"

Phrase: "W.J.,"

Phrase: "Schmechel,"

Phrase: "S. et al"

Phrase: ")."
Processing 00000000.tx.114: (1993) Association of apoliprotein E allele [epsis]4 with the late-onset familial and sporadic Alzheimer disease. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Association of apoliprotein E allele"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0004083:Association [Mental Process]
   760   C0439849:Association [Qualitative Concept]
   760   C0596306:Association [Phenomenon or Process]
   760   C0699792:association [Social Behavior]

Phrase: "[epsis"

Phrase: "]4 with the late-onset familial"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0015576:familial [Family Group]
   753   C0205087:Late [Temporal Concept]
   753   C0241888:Familial [Functional Concept]
   753   C0332162:Onset [Qualitative Concept]

Phrase: "and"

Phrase: "sporadic Alzheimer disease."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   901   C0002395:Alzheimer's Disease [Disease or Syndrome]
   901   C1521724:Alzheimer's Disease [Pathologic Function]
   827   C0012634:Disease [Disease or Syndrome]
   827   C0205422:Sporadic [Temporal Concept]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.115: Neurology, 43, 1467-1472. 

Phrase: "Neurology,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0027855:Neurology [Biomedical Occupation or Discipline]
   928 E C0205494:Neurologic [Qualitative Concept]
   928 E C2707261:Neurological [Clinical Attribute]
   907 E C0027763:Nervous System [Body System]
   907 E C0422837:NERVOUS SYSTEM [Finding]
   907 E C1269560:Nervous system [Body System]

Phrase: "43,"

Phrase: "1467-1472."
Processing 00000000.tx.116: MEDLINE Abstract 6. 

Phrase: "MEDLINE Abstract 6."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.117: Khachaturian, Z.S. 

Phrase: "Khachaturian,"

Phrase: "Z.S."
Processing 00000000.tx.118: (1985) Diagnosis of Alzheimer disease. 

Phrase: "(1985"

Phrase: ")"

Phrase: "Diagnosis of Alzheimer disease."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0011900:Diagnosis [Finding]
   770   C1704338:diagnosis [Qualitative Concept]
   770   C1704656:DIAGNOSIS [Research Activity]
Processing 00000000.tx.119: Arch. 

Phrase: "Arch."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0230467:arch [Body Location or Region]
  1000   C0741204:ARCH [Body Space or Junction]
Processing 00000000.tx.120: Neurol., 42, 1097-1105. 

Phrase: "Neurol.,"

Phrase: "42,"

Phrase: "1097-1105."
Processing 00000000.tx.121: MEDLINE Abstract 7. 

Phrase: "MEDLINE Abstract 7."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.122: McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D. and Stadlan, E.M. 

Phrase: "McKhann,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Drachman,"

Phrase: "D."

Phrase: ","

Phrase: "Folstein,"

Phrase: "M."

Phrase: ","

Phrase: "Katzman,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Price,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080045:Price [Quantitative Concept]

Phrase: "D."

Phrase: "and"

Phrase: "Stadlan,"

Phrase: "E.M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.123: (1984) Clinical diagnosis of Alzheimer disease: report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task force on Alzheimer Disease. 

Phrase: "(1984"

Phrase: ")"

Phrase: "Clinical diagnosis of Alzheimer disease"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0332140:Diagnosis, clinical [Qualitative Concept]
   760   C0011900:Diagnosis [Finding]
   760   C0205210:Clinical [Qualitative Concept]
   760   C1704338:diagnosis [Qualitative Concept]
   760   C1704656:DIAGNOSIS [Research Activity]

Phrase: ":"

Phrase: "report of the NINCDS-ADRDA Work Group"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0684224:Report [Intellectual Product]
   748   C0700287:Report [Health Care Activity]
   748   C3273238:Report [Intellectual Product]

Phrase: "under the auspices"

Phrase: "of the Department of Health and Human Services Task force"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   812   C0162458:Task Force [Governmental or Regulatory Activity]
   793   C0441722:Force [Phenomenon or Process]
   793   C0563538:Force [Phenomenon or Process]
   793   C3540678:Task [Occupational Activity]
   756   C0041711:Department of Health and Human Services [Health Care Related Organization]
           department health human services
   737 E C0729333:Dynamic [Functional Concept]

Phrase: "on Alzheimer Disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.124: Neurology, 34, 939-944. 

Phrase: "Neurology,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0027855:Neurology [Biomedical Occupation or Discipline]
   928 E C0205494:Neurologic [Qualitative Concept]
   928 E C2707261:Neurological [Clinical Attribute]
   907 E C0027763:Nervous System [Body System]
   907 E C0422837:NERVOUS SYSTEM [Finding]
   907 E C1269560:Nervous system [Body System]

Phrase: "34,"

Phrase: "939-944."
Processing 00000000.tx.125: MEDLINE Abstract 8. 

Phrase: "MEDLINE Abstract 8."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.126: Gearing, M., Mirra, S.S., Hedreen, J.C., Sumi, S.M., Hansen, L.A. and Heyman, A. 

Phrase: "Gearing,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1706469:Gear [Qualitative Concept]
   966   C1706470:Gear [Manufactured Object]

Phrase: "M."

Phrase: ","

Phrase: "Mirra,"

Phrase: "S.S.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603362:S' [Clinical Attribute]

Phrase: "Hedreen,"

Phrase: "J.C., Sumi,"

Phrase: "S.M.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
   861   C2603362:S' [Clinical Attribute]

Phrase: "Hansen,"

Phrase: "L.A."

Phrase: "and"

Phrase: "Heyman,"

Phrase: "A."
Processing 00000000.tx.127: (1995) The consortium to establish a registry for Alzheimer disease (CERAD). 

Phrase: "(1995"

Phrase: ")"

Phrase: "The consortium to establish a registry for Alzheimer disease (CERAD)."
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   812   C0002395:Alzheimer's Disease [Disease or Syndrome]
   812   C1521724:Alzheimer's Disease [Pathologic Function]
   793   C0012634:Disease [Disease or Syndrome]
   793   C0034975:Registry [Intellectual Product]
   793   C0443211:establish [Qualitative Concept]
   793   C1513822:Consortium [Professional or Occupational Group]
   793   C1880171:Consortium [Professional or Occupational Group]
   737 E C1836721:MALS [Finding]
   737 E C3538764:MALS [Gene or Genome]
   737 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.128: Part X. 

Phrase: "Part X."
Processing 00000000.tx.129: Neuropathologic confirmation of the clinical diagnosis of Alzheimer disease. 

Phrase: "Neuropathologic confirmation of the clinical diagnosis of Alzheimer disease."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   764   C0521091:Confirmation of [Qualitative Concept]
           confirmation
   742   C0750484:Confirmation [Idea or Concept]
Processing 00000000.tx.130: Neurology, 45, 461-466. 

Phrase: "Neurology,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0027855:Neurology [Biomedical Occupation or Discipline]
   928 E C0205494:Neurologic [Qualitative Concept]
   928 E C2707261:Neurological [Clinical Attribute]
   907 E C0027763:Nervous System [Body System]
   907 E C0422837:NERVOUS SYSTEM [Finding]
   907 E C1269560:Nervous system [Body System]

Phrase: "45,"

Phrase: "461-466."
Processing 00000000.tx.131: MEDLINE Abstract 9. 

Phrase: "MEDLINE Abstract 9."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.132: Sherrington, R., Rogaev, E., Liang, Y. et al). 

Phrase: "Sherrington,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Rogaev,"

Phrase: "E.,"

Phrase: "Liang,"

Phrase: "Y. et al"

Phrase: ")."
Processing 00000000.tx.133: (1995) Cloning of a gene bearing missense mutations in early onset familial Alzheimer's disease. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Cloning of a gene bearing missense mutations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C0598888:Gene Cloning [Laboratory Procedure,Molecular Biology Research Technique]
   748   C0009015:Cloning [Research Activity]

Phrase: "in early onset familial Alzheimer's disease."
Meta Candidates (Total=14; Excluded=5; Pruned=0; Remaining=9)
   924   C0750901:Alzheimer Disease, Early Onset [Disease or Syndrome]
   897   C0679245:early disease [Temporal Concept]
   884   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   853   C0277558:Familial disease [Disease or Syndrome]
   840   C0002395:Alzheimer's Disease [Disease or Syndrome]
   840   C1521724:Alzheimer's Disease [Pathologic Function]
   817 E C0344339:family disease [Finding]
   804   C0012634:Disease [Disease or Syndrome]
   804   C0015576:familial [Family Group]
   804   C0241888:Familial [Functional Concept]
   748 E C1836721:MALS [Finding]
   748 E C3538764:MALS [Gene or Genome]
   748 E C3540595:MAL [Gene or Genome]
   733 E C1704727:Family [Conceptual Entity]
Processing 00000000.tx.134: Nature, 375, 754-760. 

Phrase: "Nature,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]

Phrase: "375,"

Phrase: "754-760."
Processing 00000000.tx.135: MEDLINE Abstract 10. 

Phrase: "MEDLINE Abstract 10."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.136: Rogaev, E.I., Sherrington, R., Rogaeva, E.A. et al). 

Phrase: "Rogaev,"

Phrase: "E.I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Sherrington,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Rogaeva,"

Phrase: "E.A. et al"

Phrase: ")."
Processing 00000000.tx.137: (1995) Familial Alzheimer's disease in kindreds with missense mutations in a novel gene on chromosome 1 related to the Alzheimer's disease type 3 gene. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Familial Alzheimer's disease in kindreds"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   862   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   806   C0002395:Alzheimer's Disease [Disease or Syndrome]
   806   C1521724:Alzheimer's Disease [Pathologic Function]
   797   C0277558:Familial disease [Disease or Syndrome]
   762 E C0344339:disease family [Finding]
   760   C0012634:Disease [Disease or Syndrome]
   760   C0015576:familial [Family Group]
   760   C0241888:Familial [Functional Concept]
   704 E C1836721:MALS [Finding]
   704 E C3538764:MALS [Gene or Genome]
   704 E C3540595:MAL [Gene or Genome]

Phrase: "with missense mutations"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0599155:Mutations, Missense [Genetic Function]
   861   C0026882:Mutations [Genetic Function]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "in a novel gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Gene [Gene or Genome]

Phrase: "on chromosome 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0008651:Chromosome 1 [Cell Component]
   861   C0008633:Chromosome [Cell Component]

Phrase: "related to the Alzheimer's disease type 3 gene."
Meta Candidates (Total=18; Excluded=1; Pruned=0; Remaining=17)
   833   C1843013:Alzheimer disease type 3 [Disease or Syndrome]
           Alzheimer disease 3
   819   C2986918:Alzheimer Disease 3 Gene [Gene or Genome]
   770   C0002395:Alzheimer's Disease [Disease or Syndrome]
   770   C0441731:Type 3 [Classification]
   770   C0457464:disease type [Intellectual Product]
   770   C1521724:Alzheimer's Disease [Pathologic Function]
   767   C0314611:Gene type [Genetic Function]
   744   C0012634:Disease [Disease or Syndrome]
   744   C0017337:Gene [Gene or Genome]
   744   C0332307:Type [Qualitative Concept]
   744   C0439849:Related [Qualitative Concept]
   744   C0445223:Related [Finding]
   744   C1547052:*Type [Quantitative Concept]
   739   C0067430:MAL-3 [Organic Chemical]
   739   C1416989:MAL gene [Gene or Genome]
   739   C1425077:MALS-3 [Gene or Genome]
   711 E C0163712:Relate [Organic Chemical]
Processing 00000000.tx.138: Nature, 376, 775-778. 

Phrase: "Nature,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]

Phrase: "376,"

Phrase: "775-778."
Processing 00000000.tx.139: MEDLINE Abstract 11. 

Phrase: "MEDLINE Abstract 11."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.140: Levy-Lahad, E. et al). 

Phrase: "Levy-Lahad,"

Phrase: "E. et al"

Phrase: ")."
Processing 00000000.tx.141: (1995) A familial Alzheimer's disease locus on chromosome 1. 

Phrase: "(1995"

Phrase: ")"

Phrase: "A familial Alzheimer's disease locus on chromosome 1."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1708726:Locus [Gene or Genome]
Processing 00000000.tx.142: Science, 269, 970-973. 

Phrase: "Science,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]

Phrase: "269,"

Phrase: "970-973."
Processing 00000000.tx.143: MEDLINE Abstract 12. 

Phrase: "MEDLINE Abstract 12."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.144: Goate, A.M., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Guiffra, L., Haynes, A. and Hardy, J.A. 

Phrase: "Goate,"

Phrase: "A.M.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2346751:A/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Chartier-Harlin,"

Phrase: "M.-C.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Mullan,"

Phrase: "M."

Phrase: ","

Phrase: "Brown,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678579:Brown [Natural Phenomenon or Process]

Phrase: "J.,"

Phrase: "Crawford,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Fidani,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Guiffra,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Haynes,"

Phrase: "A."

Phrase: "and"

Phrase: "Hardy,"

Phrase: "J."

Phrase: "A."
Processing 00000000.tx.145: (1991) Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer disease. 

Phrase: "(1991"

Phrase: ")"

Phrase: "Segregation of a missense mutation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0080141:segregation [Social Behavior]

Phrase: "in the amyloid precursor protein gene"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0751455:protein gene [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0017337:Gene [Gene or Genome]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "with familial Alzheimer disease."
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   913   C0277558:Familial disease [Disease or Syndrome]
   901   C0002395:Alzheimer's Disease [Disease or Syndrome]
   901   C1521724:Alzheimer's Disease [Pathologic Function]
   877 E C0344339:family disease [Finding]
   827   C0012634:Disease [Disease or Syndrome]
   827   C0015576:familial [Family Group]
   827   C0241888:Familial [Functional Concept]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]
   755 E C1704727:Family [Conceptual Entity]
Processing 00000000.tx.146: Nature, 349, 704-706. 

Phrase: "Nature,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]

Phrase: "349,"

Phrase: "704-706."
Processing 00000000.tx.147: MEDLINE Abstract 13. 

Phrase: "MEDLINE Abstract 13."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.148: Hendricks, M., van Duijn, C.M., Cras, P. et al). 

Phrase: "Hendricks,"

Phrase: "M."

Phrase: ","

Phrase: "van Duijn,"

Phrase: "C."

Phrase: "M."

Phrase: ","

Phrase: "Cras,"

Phrase: "P. et al"

Phrase: ")."
Processing 00000000.tx.149: (1992) Presenile dementia and cerebral hemorrhage linked to a mutation at codon 692 of the B-amyloid precursor protein gene. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Presenile dementia"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0011265:Pre-senile dementia [Mental or Behavioral Dysfunction]
           dementia
   861   C0497327:Dementia [Mental or Behavioral Dysfunction]
   761 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "and"

Phrase: "cerebral hemorrhage"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2937358:Cerebral Hemorrhage [Pathologic Function]
   861   C0019080:Haemorrhage [Pathologic Function]

Phrase: "linked to a mutation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0026882:Mutation [Genetic Function]
   770   C1705285:Mutation [Cell or Molecular Dysfunction]
   737   C1517892:Link [Intellectual Product]
   737   C1704666:Link [Intellectual Product]

Phrase: "at codon 692"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0009221:Codon [Nucleotide Sequence]
   861   C1095825:Codon [Plant]

Phrase: "of the B-amyloid precursor protein gene."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   840   C0751455:protein gene [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0017337:Gene [Gene or Genome]
   717   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   717   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C0377800:b protein [Amino Acid, Peptide, or Protein,Receptor]
   708   C1336694:b-PROTEIN [Gene or Genome]
   708   C1455498:B-Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.150: Nature Genet., 1, 218-221. 

Phrase: "Nature Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0325074:Genet [Mammal]

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "218-221."
Processing 00000000.tx.151: 14. 

Phrase: "14."
Processing 00000000.tx.152: Mullan, M.J., Crawford, F., Axelman, K., Houlden, H., Lilius, L., Winblad, B., Lannfelt, L. and Hardy, J. 

Phrase: "Mullan,"

Phrase: "M."

Phrase: "J.,"

Phrase: "Crawford,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Axelman,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Houlden,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Lilius,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Winblad,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Lannfelt,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Hardy,"

Phrase: "J."
Processing 00000000.tx.153: (1992) A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of B-amyloid. 

Phrase: "(1992"

Phrase: ")"

Phrase: "A pathogenic mutation for probable Alzheimer's disease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0026882:Mutation [Genetic Function]
   748   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "in the APP gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1364818:APP gene [Gene or Genome]
   861   C0017337:Gene [Gene or Genome]

Phrase: "at the N-terminus"

Phrase: "of B-amyloid."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0011560:Amyloid [Pathologic Function]
   861   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.154: Nature Genet., 1, 345-347. 

Phrase: "Nature Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0325074:Genet [Mammal]

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "345-347."
Processing 00000000.tx.155: MEDLINE Abstract 15. 

Phrase: "MEDLINE Abstract 15."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.156: SAS User's Guide: Statistics. 

Phrase: "SAS User's Guide"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0181090:Guide [Professional or Occupational Group]
   827   C0302614:Guide [Medical Device]
   827   C1706050:Guide [Manufactured Object]

Phrase: ":"

Phrase: "Statistics."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0038215:Statistics [Occupation or Discipline]
  1000   C0600673:Statistics [Intellectual Product]
   966 E C2348149:Statistic [Quantitative Concept]
   966 E C2828391:Statistic [Quantitative Concept]
Processing 00000000.tx.157: 1992, SAS Institute Inc., Cary, NC. 

Phrase: "1992,"

Phrase: "SAS Institute Inc.,"

Phrase: "Cary,"

Phrase: "NC."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0027964:NC [Geographic Area]
  1000   C0028407:NC [Geographic Area]
  1000   C0067895:NC [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.158: 16. 

Phrase: "16."
Processing 00000000.tx.159: Kruglyak, L., Daly, M.J., Reeve-Daly, M.P. and Lander, E.S. 

Phrase: "Kruglyak,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Daly,"

Phrase: "M."

Phrase: "J.,"

Phrase: "Reeve-Daly,"

Phrase: "M."

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Lander,"

Phrase: "E.S."
Processing 00000000.tx.160: (1996) Parametric and non-parametric linkage analysis: a unified multipoint approach. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Parametric"

Phrase: "and"

Phrase: "non-parametric linkage analysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0796345:linkage analysis [Laboratory Procedure]
   812   C0002778:Analysis [Laboratory Procedure]
   812   C0936012:Analysis [Research Activity]
   812   C1524024:analysis [Functional Concept]

Phrase: ":"

Phrase: "a unified multipoint approach."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0449445:Approach [Spatial Concept]
Processing 00000000.tx.161: Am. 

Phrase: "Am."
Processing 00000000.tx.162: J. 

Phrase: "J."
Processing 00000000.tx.163: Hum. 

Phrase: "Hum."
Processing 00000000.tx.164: Genet., 58, 1347-1363. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "58,"

Phrase: "1347-1363."
Processing 00000000.tx.165: MEDLINE Abstract 17. 

Phrase: "MEDLINE Abstract 17."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.166: Farrer, L.A. and Stice, L. 

Phrase: "Farrer,"

Phrase: "L.A."

Phrase: "and"

Phrase: "Stice,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.167: (1993) Susceptibility genes for familial Alzheimer's disease on chromosomes 19 and 21: a reality check. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Susceptibility genes for familial Alzheimer's disease"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   773   C0919453:Susceptibility Gene [Gene or Genome]
   753   C0017337:Genes [Gene or Genome]
   739   C1416989:MAL gene [Gene or Genome]
   731   C1517488:Gene Family [Gene or Genome]

Phrase: "on chromosomes 19"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C0008661:Chromosome 19 [Cell Component]
   861   C0008633:Chromosomes [Cell Component]

Phrase: "and"

Phrase: "21"

Phrase: ":"

Phrase: "a reality check."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1283174:Check [Activity]
   861   C1555524:Cheque [Intellectual Product]
Processing 00000000.tx.168: Genet. 

Phrase: "Genet."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]
Processing 00000000.tx.169: Epidemiol., 10, 425-430. 

Phrase: "Epidemiol.,"

Phrase: "10,"

Phrase: "425-430."
Processing 00000000.tx.170: MEDLINE Abstract 18. 

Phrase: "MEDLINE Abstract 18."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.171: Farrer, L.A., Myers, R.H., Cupples, L.A., St George-Hyslop, P.H., Bird, T.D., Rossor, M.N. et al). 

Phrase: "Farrer,"

Phrase: "L.A.,"

Phrase: "Myers,"

Phrase: "R.H.,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0205090:R- [Spatial Concept]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Cupples,"

Phrase: "L.A.,"

Phrase: "St George-Hyslop,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1553316:St. George [Population Group]

Phrase: "P.H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Bird,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005595:Bird [Bird]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "D."

Phrase: ","

Phrase: "Rossor,"

Phrase: "M."

Phrase: "N. et al"

Phrase: ")."
Processing 00000000.tx.172: (1990) Transmission and age-at-onset patterns in familial Alzheimer disease: evidence for heterogeneity. 

Phrase: "(1990"

Phrase: ")"

Phrase: "Transmission"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0040722:transmission [Idea or Concept]
  1000   C0242781:Transmission [Pathologic Function]
  1000   C1521797:Transmission [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "age-at-onset patterns in familial Alzheimer disease"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0449774:Patterns [Spatial Concept]

Phrase: ":"

Phrase: "evidence for heterogeneity."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0332120:Evidence [Functional Concept]
Processing 00000000.tx.173: Neurology, 40, 395-403. 

Phrase: "Neurology,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0027855:Neurology [Biomedical Occupation or Discipline]
   928 E C0205494:Neurologic [Qualitative Concept]
   928 E C2707261:Neurological [Clinical Attribute]
   907 E C0027763:Nervous System [Body System]
   907 E C0422837:NERVOUS SYSTEM [Finding]
   907 E C1269560:Nervous system [Body System]

Phrase: "40,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: "395-403."
Processing 00000000.tx.174: MEDLINE Abstract 19. 

Phrase: "MEDLINE Abstract 19."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0000857:Abstract [Occupational Activity]
   827   C0025141:MEDLINE [Intellectual Product]
   827   C0600678:Abstract [Intellectual Product]
   827   C1552863:Abstract [Idea or Concept]
Processing 00000000.tx.175: Ott, J. 

Phrase: "Ott,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1423088:OTT [Gene or Genome]
  1000   C3273338:OTT [Gene or Genome]

Phrase: "J."
Processing 00000000.tx.176: (1991) Analysis of Human Genetic Linkage. 

Phrase: "(1991"

Phrase: ")"

Phrase: "Analysis of Human Genetic Linkage."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   844   C0796345:genetic linkage analysis [Laboratory Procedure]
           analysis linkage
   797   C0679560:genetic analysis [Laboratory Procedure]
   797   C0796344:Genetic Analysis [Laboratory Procedure]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]
Processing 00000000.tx.177: Johns Hopkins University Press, Baltimore, MD. 

Phrase: "Johns Hopkins University Press,"

Phrase: "Baltimore,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004716:Baltimore [Geographic Area]

Phrase: "MD."
Processing 00000000.tx.178: *To whom correspondence should be addressed. 

Phrase: "*"

Phrase: "To whom correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "should"

Phrase: "be"

Phrase: "addressed."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]
Processing 00000000.tx.179: Tel: +1 416 978 7460; 

Phrase: "Tel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0254343:TEL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0796520:TEL [Gene or Genome]
  1000   C3272379:TEL [Intellectual Product]

Phrase: ":"

Phrase: "+1 416 978 7460"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C2827734:1+ [Quantitative Concept]
   812   C2981698:1+ [Classification]

Phrase: ";"
Processing 00000000.tx.180: Fax: +1 416 978 1878; 

Phrase: "Fax"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085205:Fax [Manufactured Object]
  1000   C1549619:FAX [Conceptual Entity]
  1000   C1880669:Fax [Manufactured Object]

Phrase: ":"

Phrase: "+1 416 978 1878"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C2827734:1+ [Quantitative Concept]
   812   C2981698:1+ [Classification]

Phrase: ";"
Processing 00000000.tx.181: Email: p.hyslop@utoronto.ca +These authors contributed equally to this manuscript This page is run by Oxford University Press, Great Clarendon Street, Oxford OX2 6DP, as part of the OUP Journals Comments and feedback: www-admin{at}oup.co.uk Last modification: 4 Apr 1998 Copyright Oxford University Press, 1998.

Phrase: "Email"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]

Phrase: ":"

Phrase: "p.hyslop@utoronto.ca +"

Phrase: "These authors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0221193:Authors [Professional or Occupational Group]

Phrase: "contributed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1880177:Contribute [Activity]

Phrase: "equally to this manuscript"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0600659:Manuscript [Intellectual Product,Manufactured Object]

Phrase: "This page"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704732:Page [Intellectual Product]

Phrase: "is"

Phrase: "run by Oxford University Press,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0035953:run [Daily or Recreational Activity]
   760   C0041740:University [Manufactured Object,Organization]
   760   C0600140:run [Finding]
   760   C1704688:Run [Functional Concept]
   760   C2346414:Run [Finding]

Phrase: "Great Clarendon Street,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0442658:Street [Manufactured Object]
   827   C1301826:Street [Finding]

Phrase: "Oxford OX2 6DP,"

Phrase: "as"

Phrase: "part of the OUP Journals Comments"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1292711:Part of [Spatial Concept]
   753   C0449719:Part [Spatial Concept]
   753   C1709471:Part [Quantitative Concept]

Phrase: "and"

Phrase: "feedback"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015744:Feedback [Phenomenon or Process]
  1000   C2911691:Feedback [Mental Process]

Phrase: ":"

Phrase: "www-admin{at}oup.co.uk Last modification"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0392747:Modification [Functional Concept]
   793   C1554963:modification [Qualitative Concept]

Phrase: ":"

Phrase: "4 Apr 1998 Copyright Oxford University Press,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0041740:University [Manufactured Object,Organization]

Phrase: "1998."

